{
  "meta": {
    "id": "test1",
    "title": "Cardiology",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 60-year-old woman with a recent type B aortic dissection presents with abdominal pain and lower limb ischemia with diminished femoral and popliteal pulses. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Add intravenous enalaprilat",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase nitroprusside infusion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Repair the descending aorta",
          "correct": true
        },
        {
          "label": "D",
          "text": "Switch nitroprusside to amlodipine",
          "correct": false
        }
      ],
      "correct_answer": "C. Repair the descending aorta",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Repair the descending aorta</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Enalaprilat: Although used for blood pressure control, it doesn't address the underlying issue of malperfusion.</li><li>\u2022 Option A. Enalaprilat:</li><li>\u2022 Option B. Increasing nitroprusside: May help with blood pressure control but doesn't solve the urgent need for revascularization.</li><li>\u2022 Option B. Increasing nitroprusside:</li><li>\u2022 Option D.  Switching to amlodipine: Not appropriate in an acute setting requiring immediate intervention.</li><li>\u2022 Option D.  Switching to amlodipine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Recognize the signs of complicated type B aortic dissection (malperfusion syndromes) and the need for immediate surgical/endovascular repair.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3d15e056",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman with Marfan syndrome has an ascending aortic diameter of 4.3 cm, which has increased by 0.6 cm in the past year. Her mother had an aortic dissection. She is considering pregnancy. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Add atorvastatin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Add losartan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aortic repair before pregnancy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Proceed with pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "C. Aortic repair before pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Aortic repair before pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Atorvastatin: Statins are not indicated for aortic disease management in this context and are contraindicated in pregnancy.</li><li>\u2022 Option A. Atorvastatin:</li><li>\u2022 Option B.  Losartan: Contraindicated in pregnancy due to fetal toxicity.</li><li>\u2022 Option B.  Losartan:</li><li>\u2022 Option D. Proceeding with pregnancy without aortic repair would be dangerous due to the high risk of dissection.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Patients with Marfan syndrome have an increased risk for pregnancy-related aortic dissection and rupture; aortic repair surgery is recommended before conception to reduce this risk in those with an ascending aortic diameter greater than 4.0 cm and who have risk factors for aortic dissection.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbe1aaa3",
      "audio": ""
    },
    {
      "text": "A 57-year-old man with acute chest pain. ECG shows multifocal ST depressions. His BP is 170/100 mm Hg on the right arm and 140/90 mm Hg in the left arm. He also has a diastolic murmur at the left sternal border. What is the most appropriate diagnostic test?",
      "options": [
        {
          "label": "A",
          "text": "Coronary Angiogram",
          "correct": false
        },
        {
          "label": "B",
          "text": "Invasive aortography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Magnetic resonance angiography (MRA)",
          "correct": false
        },
        {
          "label": "D",
          "text": "CT Angiography",
          "correct": true
        }
      ],
      "correct_answer": "D. CT Angiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Coronary angiography: Relatively contraindicated in suspected aortic dissection.</li><li>\u2022 Option A.  Coronary angiography:</li><li>\u2022 Option B. Invasive aortography: Less commonly used compared to CTA for diagnosis.</li><li>\u2022 Option B.</li><li>\u2022 Option C.  MRA: Time consuming and unnecessary in an emergency like in this case.</li><li>\u2022 Option C.  MRA:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with suspected aortic dissection, perform TTE and CT angiography promptly for diagnosis and to guide management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "be3dc438",
      "audio": ""
    },
    {
      "text": "A 73-year-old woman with extensive cardiovascular disease and poorly controlled hypertension is evaluated for acute-onset ripping chest pain that radiates to her back. Chest radiograph is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute coronary syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aortic dissection",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pulmonary embolism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stress-induced cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "B. Aortic dissection",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/untitled-3.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The most likely diagnosis is acute aortic dissection. This patient's chest radiograph shows a widened superior mediastinum and a right pleural effusion consistent with aortic dissection, although these findings are not diagnostic. The diagnosis of aortic dissection can be established with transesophageal echocardiography, CT angiography, or MR angiography, all of which have similar sensitivity and specificity for acute thoracic aortic disease. Because of its wide availability and short image acquisition time, CT angiography has become the primary diagnostic test for acute thoracic aortic disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7b1201cd",
      "audio": ""
    },
    {
      "text": "A 76-year-old man with peripheral artery disease (PAD) and persistent claudication despite exercise and optimal medical therapy (aspirin, statin, enalapril). What is the most appropriate additional treatment?",
      "options": [
        {
          "label": "A",
          "text": "Cilostazol",
          "correct": true
        },
        {
          "label": "B",
          "text": "Clopidogrel",
          "correct": false
        },
        {
          "label": "C",
          "text": "Evolocumab",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pentoxifylline",
          "correct": false
        }
      ],
      "correct_answer": "A. Cilostazol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Clopidogrel : Dual antiplatelet therapy is not routinely recommended for PAD.</li><li>\u2022 Option B. Clopidogrel</li><li>\u2022 Option C. Evolocumab : PCSK9 inhibitors are for patients with high LDL cholesterol despite statin therapy.</li><li>\u2022 Option C. Evolocumab</li><li>\u2022 Option D. Pentoxifylline : Not proven effective for claudication.</li><li>\u2022 Option D. Pentoxifylline</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients with peripheral artery disease and intermittent claudication, cilostazol is recommended to improve limb symptoms in addition to smoking cessation, aspirin, statin therapy, and supervised exercise.</li><li>\u27a4 Cilostazol is contraindicated in patients with heart failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f507504d",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman with acute chest pain for the last 3 hours. Aspirin and clopidogrel was given in the ambulance. ECG is taken in ER and shown below. What is the next step?",
      "options": [
        {
          "label": "A",
          "text": "Reteplase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tirofiban",
          "correct": false
        },
        {
          "label": "C",
          "text": "Enoxaparin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Emergent coronary angiography",
          "correct": false
        }
      ],
      "correct_answer": "C. Enoxaparin",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171044.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Reteplase : This is a thrombolytic agent used in STEMI and not in NSTE-ACS.</li><li>\u2022 Option A. Reteplase</li><li>\u2022 Option B. Tirofiban : GpIIb/IIIa inhibitor used primarily during PCI under special circumstances.</li><li>\u2022 Option B. Tirofiban</li><li>\u2022 Option D. Emergent Coronary angiography : While angiography is crucial to confirm the diagnosis and guide further management, immediate anticoagulation with enoxaparin should be initiated first. In this patient with ST depression (a high risk factor), URGENT coronary angiography is optimal (< 24h) rather than immediate (< 2h).</li><li>\u2022 Option D. Emergent Coronary angiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with suspected NSTE-ACS, early administration of enoxaparin is crucial to prevent further thrombus formation while awaiting coronary angiography.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9fd7b7fd",
      "audio": ""
    },
    {
      "text": "A 57-year-old man with exertional chest pain and a positive stress test undergoes angiography revealing complex multivessel coronary artery disease (CAD) involving the left main. He has a left ventricular ejection fraction (LVEF) of 42%. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Coronary artery bypass grafting (CABG)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Medical therapy without revascularization",
          "correct": false
        },
        {
          "label": "C",
          "text": "Myocardial viability testing",
          "correct": false
        },
        {
          "label": "D",
          "text": "Percutaneous coronary intervention (PCI)",
          "correct": false
        }
      ],
      "correct_answer": "A. Coronary artery bypass grafting (CABG)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Medical therapy : Insufficient for complex CAD and reduced LVEF, carries a higher risk of adverse events.</li><li>\u2022 Option B. Medical therapy</li><li>\u2022 Option C. Viability testing : Not necessary before revascularization in this scenario.</li><li>\u2022 Option C. Viability testing</li><li>\u2022 Option D. PCI : Less favorable than CABG for complex multivessel disease, especially with left main involvement.</li><li>\u2022 Option D. PCI</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients with multivessel coronary artery disease, coronary artery bypass grafting is associated with enhanced survival compared with medical therapy alone.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d47dd165",
      "audio": ""
    },
    {
      "text": "A 60-year-old man with a history of hypertension and coronary artery disease presents with acute decompensated heart failure. He is dyspneic at rest and has bibasilar crackles on lung auscultation. Which of the following medications is NOT appropriate for initial",
      "options": [
        {
          "label": "A",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Nitroglycerin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Verapamil",
          "correct": true
        },
        {
          "label": "D",
          "text": "CPAP",
          "correct": false
        }
      ],
      "correct_answer": "C. Verapamil",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Furosemide : Loop diuretic, cornerstone of therapy in ADHF to reduce fluid overload.</li><li>\u2022 Option A. Furosemide</li><li>\u2022 Option B. Nitroglycerin : Vasodilator, used to reduce preload and afterload, improving cardiac function in ADHF.</li><li>\u2022 Option B. Nitroglycerin</li><li>\u2022 Option D. CPAP : Non-invasive ventilation, often used in ADHF to improve oxygenation and decrease the work of breathing.</li><li>\u2022 Option D. CPAP</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Non-dihydropyridine calcium channel blockers (like verapamil) are C/I in acute decompensated heart failure due to their negative inotropic effects</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "87d49219",
      "audio": ""
    },
    {
      "text": "A 57-year-old man with stable angina and aspirin allergy is undergoing lifestyle counseling and antianginal therapy. What is the most appropriate cardioprotective treatment?",
      "options": [
        {
          "label": "A",
          "text": "Clopidogrel",
          "correct": true
        },
        {
          "label": "B",
          "text": "Low-dose aspirin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prasugrel",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ticagrelor",
          "correct": false
        }
      ],
      "correct_answer": "A. Clopidogrel",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Low-dose aspirin : Contraindicated due to aspirin allergy.</li><li>\u2022 Option B. Low-dose aspirin</li><li>\u2022 Option C. Prasugrel and Option D. Ticagrelor : More potent antiplatelet agents, typically used in acute coronary syndrome or after PCI, not as monotherapy for stable angina.</li><li>\u2022 Option C. Prasugrel</li><li>\u2022 Option</li><li>\u2022 D. Ticagrelor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 All patients with stable ischemic heart disease should receive guideline-directed therapies consisting of lifestyle modification, cardioprotective therapy, and antianginal medication. Patients with stable ischemic heart disease should receive antiplatelet therapy (low-dose aspirin or clopidogrel in aspirin-intolerant patients) for secondary prevention of cardiovascular events.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "feece3a5",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with decompensated heart failure is hospitalized and treated with a maximal dose of IV furosemide. He has minimal urine output and persistent signs of volume overload. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Add intravenous milrinone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Add intravenous nitroglycerin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase furosemide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Start CVVH (Continuous venovenous hemofiltration)",
          "correct": true
        }
      ],
      "correct_answer": "D. Start CVVH (Continuous venovenous hemofiltration)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Add intravenous milrinone: Milrinone is an inotrope used to improve cardiac contractility. While it may help with cardiac output, it doesn't directly address the volume overload and can worsen renal function.</li><li>\u2022 Option A. Add intravenous milrinone:</li><li>\u2022 Option B. Add intravenous nitroglycerin: Nitroglycerin is a vasodilator that can reduce preload and afterload, but it's not the primary treatment for volume overload when diuretics fail.</li><li>\u2022 Option B. Add intravenous nitroglycerin:</li><li>\u2022 Option C. Increase furosemide: The patient is already on the maximal dose of furosemide, so further increases would not be effective and could lead to adverse effects.</li><li>\u2022 Option C. Increase furosemide:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients with ADHF who are unresponsive to maximal diuretic therapy, CVVH is a crucial intervention to manage volume overload and prevent further complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c3cba583",
      "audio": ""
    },
    {
      "text": "A 33-year-old woman 3 months postpartum presents with recurrent exertional chest pain. Cardiac catheterization shows normal coronary arteries, and cardiac MRI reveals diffuse perfusion abnormalities. What is the most likely cause?",
      "options": [
        {
          "label": "A",
          "text": "Coronary vasospasm",
          "correct": false
        },
        {
          "label": "B",
          "text": "Microvascular dysfunction",
          "correct": true
        },
        {
          "label": "C",
          "text": "Peripartum cardiomyopathy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Spontaneous coronary artery dissection",
          "correct": false
        }
      ],
      "correct_answer": "B. Microvascular dysfunction",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Coronary vasospasm : This would cause transient ST-elevation on ECG.</li><li>\u2022 Option A. Coronary vasospasm</li><li>\u2022 Option C. Peripartum cardiomyopathy : Presents with heart failure symptoms, not typically isolated chest pain.</li><li>\u2022 Option C. Peripartum cardiomyopathy</li><li>\u2022 Option D. Spontaneous coronary artery dissection : More common in the peripartum period but would typically have abnormal coronary angiography findings.</li><li>\u2022 Option D. Spontaneous coronary artery dissection</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Consider microvascular dysfunction as a potential cause of angina in women with normal coronary arteries on angiography.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0ecd64d3",
      "audio": ""
    },
    {
      "text": "A 60-year-old woman with diabetes mellitus received a drug-eluting stent for non-ST elevation acute coronary syndrome (NSTE-ACS). She was started on dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. What is the recommended minimum duration of her antiplatelet therapy?",
      "options": [
        {
          "label": "A",
          "text": "1 month",
          "correct": false
        },
        {
          "label": "B",
          "text": "3 months",
          "correct": false
        },
        {
          "label": "C",
          "text": "6 months",
          "correct": false
        },
        {
          "label": "D",
          "text": "12 months",
          "correct": true
        }
      ],
      "correct_answer": "D. 12 months",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. 1 month: This duration is too short and would significantly increase the risk of stent thrombosis.</li><li>\u2022 Option A. 1 month:</li><li>\u2022 Option B. 3 months: While some studies suggest shorter durations may be safe in select patients, the standard recommendation for patients with diabetes is 12 months.</li><li>\u2022 Option B. 3 months:</li><li>\u2022 Option C. 6 months: This is the minimum duration for patients without diabetes who have received a drug-eluting stent for ACS.</li><li>\u2022 Option</li><li>\u2022 C. 6 months:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understand the recommended duration of dual antiplatelet therapy in patients with diabetes who have undergone percutaneous coronary intervention (PCI) with drug-eluting stents for acute coronary syndrome.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "84130da6",
      "audio": ""
    },
    {
      "text": "A 69-year-old man with persistent angina despite maximally tolerated antianginal therapy. He has orthostatic hypotension and current BP and PR are 100/60 mm Hg and 54/min respectively. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Addition of clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Addition of isosorbide mononitrate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coronary angiography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Exercise echocardiography",
          "correct": false
        }
      ],
      "correct_answer": "C. Coronary angiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Addition of Clopidogrel : Not indicated for stable angina without recent revascularization.</li><li>\u2022 Option A. Addition of Clopidogrel</li><li>\u2022 Option B. Addition of Isosorbide mononitrate : Adding more antianginal medication may not be helpful if the patient is already on maximally tolerated doses. Addition of nitrate in this patient may worsen orthostatic hypotension.</li><li>\u2022 Option B. Addition of Isosorbide mononitrate</li><li>\u2022 Option D. Exercise echocardiography : May provide prognostic information but doesn't identify lesions for revascularization.</li><li>\u2022 Option D. Exercise echocardiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In the setting of persistent symptoms despite maximally tolerated medical therapy, invasive imaging for revascularization assessment is appropriate to improve symptom status and quality of life.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1049ff63",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with a 6.1 cm abdominal aortic aneurysm (AAA) detected on routine USG screening. What is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Abdominal aortography",
          "correct": false
        },
        {
          "label": "B",
          "text": "ACE inhibitor therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "CT angiography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Open abdominal aortic aneurysm repair",
          "correct": false
        }
      ],
      "correct_answer": "C. CT angiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Abdominal aortography : Invasive and less commonly used for AAA evaluation.</li><li>\u2022 Option A. Abdominal aortography</li><li>\u2022 Option B. ACE inhibitor therapy : Doesn't address the need for repair of a large AAA.</li><li>\u2022 Option B. ACE inhibitor therapy</li><li>\u2022 Option D. Open AAA repair : Premature before confirming the location and suitability for repair with CTA.</li><li>\u2022 Option D. Open AAA repair</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The U.S. Preventive Services Task Force recommends one-time screening with duplex ultrasonography in all men aged 65 to 75 years who have smoked at least 100 cigarettes in their lifetime and selective screening in men in this age group who have never smoked.</li><li>\u27a4 CT angiography or magnetic resonance angiography is the imaging procedure of choice to identify the exact location of an abdominal aneurysm and plan operative repair.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "da129fd1",
      "audio": ""
    },
    {
      "text": "A 74-year-old man with Alzheimer's disease, on donepezil, presents with somnolence, hypotension (70/40 mmHg), and sinus bradycardia (30/min). What is the next treatment?",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chest compressions",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intravenous atropine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Isoproterenol",
          "correct": false
        }
      ],
      "correct_answer": "C. Intravenous atropine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Amiodarone : Antiarrhythmic drug, not indicated for bradycardia.</li><li>\u2022 Option A. Amiodarone</li><li>\u2022 Option B. Chest compressions : Not indicated if the patient has a pulse.</li><li>\u2022 Option B. Chest compressions</li><li>\u2022 Option D. Isoproterenol : Second-line chronotropic agent, considered if atropine is ineffective.</li><li>\u2022 Option D. Isoproterenol</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The treatment of hemodynamically unstable bradycardia with a pulse is intravenous atropine.</li><li>\u27a4 The most common extrinsic cause of sinus bradycardia is medication use (\u03b2-blockers, donepezil, neostigmine, pyridostigmine).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e02d94c8",
      "audio": ""
    },
    {
      "text": "A 75-year-old man with a history of atrial fibrillation, diabetes, and peripheral artery disease presents with acute left leg pain, absent pulses, and cold, mottled skin. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Angiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Apixaban",
          "correct": false
        },
        {
          "label": "C",
          "text": "Unfractionated heparin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Venous duplex ultrasonography",
          "correct": false
        }
      ],
      "correct_answer": "C. Unfractionated heparin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Angiography : Essential for diagnosis and planning revascularization, but anticoagulation should be started first.</li><li>\u2022 Option A. Angiography</li><li>\u2022 Option B. Apixaban : Oral anticoagulant, not appropriate in the acute setting of ALI.</li><li>\u2022 Option B. Apixaban</li><li>\u2022 Option D. Venous duplex ultrasonography : Not indicated for ALI, which is an arterial problem.</li><li>\u2022 Option D. Venous duplex ultrasonography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Treat acute limb ischemia with anticoagulation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9c1e1a5",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with no medical history presents with frequent, bothersome palpitations that subside with exercise and in the nights. ECG is shown. Echo and baseline lab tests including CBC and TFT are normal. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Exercise ECG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Propranolol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Reassurance",
          "correct": false
        }
      ],
      "correct_answer": "C. Propranolol",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-172502.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Amiodarone : Antiarrhythmic drug with potential toxicity, not first-line for simple PVCs.</li><li>\u2022 Option A. Amiodarone</li><li>\u2022 Option B. Exercise ECG : Not helpful for diagnosing PVCs.</li><li>\u2022 Option B. Exercise ECG</li><li>\u2022 Option D. Reassurance : Not sufficient for bothersome symptoms.</li><li>\u2022 Option D. Reassurance</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Beta-blockers are the first-line treatment for symptomatic PVCs in patients without structural heart disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "06d982a1",
      "audio": ""
    },
    {
      "text": "A 71-year-old man with a history of coronary artery bypass graft (CABG) presents with worsening exertional chest pain. He is on aspirin, metoprolol, sublingual nitroglycerin, and rosuvastatin. ECG shows LBBB. Which is the most appropriate test?",
      "options": [
        {
          "label": "A",
          "text": "Dobutamine echocardiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Exercise ECG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Exercise single-photon emission CT (SPECT)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vasodilator myocardial perfusion imaging (MPI)",
          "correct": true
        }
      ],
      "correct_answer": "D. Vasodilator myocardial perfusion imaging (MPI)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Dobutamine echocardiography : Not ideal due to the presence of LBBB, which can hinder image interpretation.</li><li>\u2022 Option A. Dobutamine echocardiography</li><li>\u2022 Option B. Exercise ECG : LBBB limits the interpretability of exercise ECG for ischemia.</li><li>\u2022 Option B. Exercise ECG</li><li>\u2022 Option C. Exercise SPECT : Exercise increases heart rate which can worsen artefacts due to LBBB.</li><li>\u2022 Option C. Exercise SPECT</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In the evaluation of patients with chest pain, vasodilator myocardial perfusion imaging with adenosine, regadenoson, or dipyridamole minimizes septal abnormalities frequently seen with exercise or dobutamine myocardial perfusion imaging.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "938fcecc",
      "audio": ""
    },
    {
      "text": "A 65-year-old man presents with recurrent chest pain and elevated troponin. ECG is shown. remains in pain despite aspirin, clopidogrel, heparin, and nitroglycerin. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Echocardiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Eplerenone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oxygen per nasal cannula",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urgent coronary angiography",
          "correct": true
        }
      ],
      "correct_answer": "D. Urgent coronary angiography",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-173300.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Echocardiography : May be helpful, but not the immediate priority.</li><li>\u2022 Option A. Echocardiography</li><li>\u2022 Option B. Eplerenone : Indicated in certain post-MI patients, but not the immediate priority for refractory angina.</li><li>\u2022 Option B. Eplerenone</li><li>\u2022 Option C. Oxygen per nasal cannula : Indicated only if the patient is hypoxic.</li><li>\u2022 Option C. Oxygen per nasal cannula</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Urgent or immediate diagnostic angiography with intent to perform revascularization is indicated in patients with NSTE-ACS who have refractory angina or hemodynamic or electrical instability.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3f5894f",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman with a history of radiation therapy for Hodgkin lymphoma presents with exertional dyspnea and a burning sensation in her throat. She has no history of hypertension, hyperlipidemia, or diabetes and she is a non-smoker. Physical examination and chest X-ray are normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Aortic stenosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Constrictive pericarditis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coronary artery disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Restrictive cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Coronary artery disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Aortic stenosis : Valvular diseases are possible after radiation but less likely given the normal physical exam.</li><li>\u2022 Option A. Aortic stenosis</li><li>\u2022 Option B . Constrictive pericarditis and Option D . Restrictive cardiomyopathy : These can occur after radiation but typically present with additional signs like elevated JVP, edema, or diastolic dysfunction.</li><li>\u2022 Option B</li><li>\u2022 Constrictive pericarditis</li><li>\u2022 Option</li><li>\u2022 D</li><li>\u2022 Restrictive cardiomyopathy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Cancer survivors who received chest radiotherapy are at risk for the late development of cardiovascular complications, including pericardial constriction, valvular heart disease, restrictive cardiomyopathy, and coronary artery disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c31fecf",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with type 2 diabetes, hypertension, hyperlipidemia, and aortofemoral bypass surgery 2 years ago has an HbA1c of 7.1%. His current medications are metformin, atenolol, ramipril, amlodipine, aspirin, rivaroxaban, and atorvastatin. Which medication is most appropriate to add for cardiovascular risk reduction?",
      "options": [
        {
          "label": "A",
          "text": "Clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Liraglutide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Niacin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pramlintide",
          "correct": false
        }
      ],
      "correct_answer": "B. Liraglutide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Clopidogrel : Patient is already on rivaroxaban and aspirin. Addition of clopidogrel would not provide any additional benefit and only increase the bleeding risk.</li><li>\u2022 Option A. Clopidogrel</li><li>\u2022 Option C. Niacin : No longer recommended for routine use due to lack of benefit and side effects.</li><li>\u2022 Option C. Niacin</li><li>\u2022 Option D. Pramlintide : Amylin analog used for glycemic control, no proven cardiovascular benefit.</li><li>\u2022 Option D. Pramlintide</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients with type 2 diabetes mellitus, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists are associated with reduced rates of adverse cardiovascular events, including stroke, myocardial infarction, and cardiovascular death, compared with placebo.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8acdc0d1",
      "audio": ""
    },
    {
      "text": "A 66-year-old woman 6-month history of right shoulder pain on exertion and it is relieved by rest. Her ECG shows LBBB. She has no known comorbidities and not on any regular medications. What is the most appropriate test?",
      "options": [
        {
          "label": "A",
          "text": "Coronary angiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Exercise ECG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pharmacologic myocardial perfusion imaging",
          "correct": true
        },
        {
          "label": "D",
          "text": "No further testing is required",
          "correct": false
        }
      ],
      "correct_answer": "C. Pharmacologic myocardial perfusion imaging",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Coronary angiography : Not the initial test for stable angina. It should be reserved for patients with a high pretest likelihood of CAD and unstable symptoms, or for those in whom optimal medical therapy has been ineffective.</li><li>\u2022 Option A. Coronary angiography</li><li>\u2022 Option B. Exercise ECG : LBBB limits interpretation of ECG changes.</li><li>\u2022 Option B. Exercise ECG</li><li>\u2022 Option D. No further testing: Inappropriate as the patient has exertional chest pain.</li><li>\u2022 Option D. No further testing:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 S tress testing with imaging is indicated in patients with an inability to exercise, baseline ECG abnormalities that limit interpretation of the exercise ECG, or indeterminate findings on the exercise ECG.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d1ec5b44",
      "audio": ""
    },
    {
      "text": "A 59-year-old man with type 2 diabetes and a history of stroke is on aspirin, metformin, olmesartan, and rosuvastatin. His LDL-C is 66 mg/dL, HDL-C is 28 mg/dL and HbA1c is 6.8%. What additional medication should be considered for CV risk reduction?",
      "options": [
        {
          "label": "A",
          "text": "Empagliflozin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ezetimibe",
          "correct": false
        },
        {
          "label": "C",
          "text": "Niacin",
          "correct": false
        },
        {
          "label": "D",
          "text": "No changes in management",
          "correct": false
        }
      ],
      "correct_answer": "A. Empagliflozin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Ezetimibe : Not indicated as LDL cholesterol is already well-controlled.</li><li>\u2022 Option B. Ezetimibe</li><li>\u2022 Option C. Niacin : Can increase HDL but no longer recommended for routine use due to lack of benefit and side effects.</li><li>\u2022 Option C. Niacin</li><li>\u2022 Option D. No changes in management : Inadequate as SGLT2 inhibitors provide additional CV benefit.</li><li>\u2022 Option D. No changes in management</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Consider adding SGLT2 inhibitors to the treatment regimen for patients with type 2 diabetes and established ASCVD to reduce CV risk.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "529899d4",
      "audio": ""
    },
    {
      "text": "A 57-year-old man presents with severe chest pain and diaphoresis. His ECG is shown below. His cardiac troponins were elevated and he was started on aspirin, ticagrelor and UFH. He experiences recurrent chest pain, hypotension and hence coronary angiogram was done which was normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Coronary plaque rupture",
          "correct": false
        },
        {
          "label": "B",
          "text": "Coronary vasospasm",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pulmonary embolism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stress cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "B. Coronary vasospasm",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-174059.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Coronary plaque rupture : Would be visible on angiography.</li><li>\u2022 Option A. Coronary plaque rupture</li><li>\u2022 Option C. Pulmonary embolism : Usually presents with pleuritic chest pain and dyspnea.</li><li>\u2022 Option C. Pulmonary embolism</li><li>\u2022 Option D. Stress cardiomyopathy : More common in elderly women and usually triggered by stress.</li><li>\u2022 Option D. Stress cardiomyopathy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Coronary vasospasm can mimic ACS and may present with recurrent chest pain, ECG changes, and even troponin elevation, despite normal coronary arteries.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6aba184",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with CAD and diabetes mellitus experiences worsening angina. He is currently on ramipril, diltiazem, metformin, atorvastatin and isosorbide mononitrate twice daily. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Add amlodipine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decrease lisinopril dosage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reduce isosorbide mononitrate dosage to once daily",
          "correct": true
        },
        {
          "label": "D",
          "text": "Repeat coronary angiography",
          "correct": false
        }
      ],
      "correct_answer": "C. Reduce isosorbide mononitrate dosage to once daily",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adding amlodipine : Not the first-line option when nitrate tolerance is suspected.</li><li>\u2022 Option A. Adding amlodipine</li><li>\u2022 Option B. Decreasing lisinopril : Not indicated as blood pressure is controlled.</li><li>\u2022 Option B. Decreasing lisinopril</li><li>\u2022 Option D. Repeat coronary angiography : Not necessary unless there is a suspicion of new coronary lesions or progression of existing ones.</li><li>\u2022 Option D. Repeat coronary angiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Long-acting nitrates provide a constant level of vasodilation and symptom relief throughout the day, but a nitrate-free interval is required to avoid tolerance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "14538cf3",
      "audio": ""
    },
    {
      "text": "An 80-year-old man with diabetes, hypertension, and hyperlipidemia presents with a 6-week history of resting foot pain and a non-healing ulcer. His ankle-brachial index (ABI) is 0.44 on the right and 0.62 on the left. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "CT angiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperbaric oxygen treatment",
          "correct": false
        },
        {
          "label": "C",
          "text": "Invasive angiography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Primary below-the-knee amputation",
          "correct": false
        }
      ],
      "correct_answer": "C. Invasive angiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. CT angiography : Can be helpful but is not the first step for patients with CLTI.</li><li>\u2022 Option A. CT angiography</li><li>\u2022 Option B. Hyperbaric oxygen treatment : Not a primary treatment for CLTI, but may be adjunctive.</li><li>\u2022 Option B. Hyperbaric oxygen treatment</li><li>\u2022 Option D. Primary amputation : Not the initial approach in patients with potentially salvageable limbs.</li><li>\u2022 Option D. Primary amputation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Chronic limb-threatening ischemia (CLTI) is characterized by more than 2 weeks of ischemic rest pain, nonhealing wound/ulcers, or gangrene in one or both legs that is attributable to objectively proven peripheral artery disease.</li><li>\u27a4 In patients with CLTI, immediate invasive angiography with endovascular revascularization is often the most effective strategy to preserve tissue viability.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f4f47738",
      "audio": ""
    },
    {
      "text": "A 73-year-old woman with chest pain over 24 hours and it is worsening despite multiple doses of NTG. She is known case of hypertension and dyslipidaemia and on enalapril and rosuvastatin. Her ECG 3 months ago was normal and her current ECG in the ER is shown. Her initial troponin is normal. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Coronary artery calcium scoring",
          "correct": false
        },
        {
          "label": "B",
          "text": "Coronary CT angiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Invasive coronary angiography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Exercise ECG",
          "correct": false
        }
      ],
      "correct_answer": "C. Invasive coronary angiography",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-174508.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Coronary artery calcium scoring : No use in patients who are already receiving statins and not helpful in the acute setting.</li><li>\u2022 Option A. Coronary artery calcium scoring</li><li>\u2022 Option B. Coronary CT angiography : May be considered, but invasive angiography is preferred for immediate diagnosis and potential intervention.</li><li>\u2022 Option B. Coronary CT angiography</li><li>\u2022 Option D. Exercise ECG : C/I in the context of acute/ongoing ischemia.</li><li>\u2022 Option D. Exercise ECG</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Invasive coronary angiography is the preferred diagnostic test in patients with refractory angina to assess coronary anatomy and guide potential revascularization.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "73257fb3",
      "audio": ""
    },
    {
      "text": "A 56-year-old man presents with inferior STEMI and he is successfully treated with PCI. He has a history of paroxysmal AF and was taking flecainide. He was also started on rivaroxaban, metoprolol, and ramipril post PCI. He is currently asymptomatic and now planned for discharge from the hospital. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Ambulatory ECG monitoring",
          "correct": false
        },
        {
          "label": "B",
          "text": "Discontinue flecainide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Discontinue metoprolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Exercise stress testing",
          "correct": false
        }
      ],
      "correct_answer": "B. Discontinue flecainide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ambulatory ECG monitoring : Helpful for assessing AF burden but doesn't address the contraindication of flecainide.</li><li>\u2022 Option A. Ambulatory ECG monitoring</li><li>\u2022 Option C. Discontinue metoprolol : Not ideal as it's essential for managing ischemic heart disease.</li><li>\u2022 Option C. Discontinue metoprolol</li><li>\u2022 Option D. Exercise stress testing : Not recommended immediately post-MI, especially with existing conduction abnormalities.</li><li>\u2022 Option D. Exercise stress testing</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Class IC antiarrhythmics like flecainide are C/I in patients with ischemic heart disease due to an increased risk of ventricular arrhythmias and death.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a8eafec3",
      "audio": ""
    },
    {
      "text": "A 58-year-old man with stable angina has persistent symptoms despite maximally tolerated medical therapy. Coronary Angiogram shows 70% proximal RCA stenosis and 80% obtuse marginal artery stenosis. What benefit can the patient expect from CABG?",
      "options": [
        {
          "label": "A",
          "text": "Discontinuation of cardioprotective medications",
          "correct": false
        },
        {
          "label": "B",
          "text": "Improvement in symptoms",
          "correct": true
        },
        {
          "label": "C",
          "text": "Increased survival",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reduced risk for myocardial infarction",
          "correct": false
        }
      ],
      "correct_answer": "B. Improvement in symptoms",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Discontinuation of medications : Not recommended after CABG.</li><li>\u2022 Option A. Discontinuation of medications</li><li>\u2022 Option C. Increased survival : Less likely in this patient without multivessel or left main disease.</li><li>\u2022 Option C. Increased survival</li><li>\u2022 Option D. Reduced risk of MI : Possible, but not the primary goal in this case.</li><li>\u2022 Option D. Reduced risk of MI</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Primary goal of revascularization instable angina is symptom relief.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0bc64a4e",
      "audio": ""
    },
    {
      "text": "A 46-year-old woman is evaluated for atypical chest pain. Exercise stress testing is performed. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hypertrophic cardiomyopathy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ischemic coronary artery disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Normal test result",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rate-dependent conduction defect",
          "correct": false
        }
      ],
      "correct_answer": "B. Ischemic coronary artery disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-174936.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "484cceb9",
      "audio": ""
    },
    {
      "text": "A 73-year-old man with a history of hypertension and hypercholesterolemia has chronic stable angina. Which of the following medications have been shown to reduce mortality and risk of myocardial infarction (MI)?",
      "options": [
        {
          "label": "A",
          "text": "Ranolazine",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u03b2-Blockers",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aspirin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Nitrates",
          "correct": false
        }
      ],
      "correct_answer": "C. Aspirin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ranolazine: Ranolazine is a newer anti-anginal medication that works by reducing myocardial oxygen demand. While it is effective in relieving angina symptoms, it has not been shown to reduce mortality or MI risk.</li><li>\u2022 Option A. Ranolazine:</li><li>\u2022 Option B. \u03b2-Blockers: Beta-blockers are first-line therapy for chronic stable angina. They reduce myocardial oxygen demand by decreasing heart rate and contractility. While they are effective in controlling angina symptoms and improving exercise tolerance, their impact on mortality is less clear.</li><li>\u2022 Option B. \u03b2-Blockers:</li><li>\u2022 Option D. Nitrates: Nitrates are potent vasodilators that improve myocardial blood flow and reduce angina symptoms. They are primarily used for symptom relief and do not have a significant impact on mortality or MI risk.</li><li>\u2022 Option D. Nitrates:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Aspirin reduces mortality and MI risk in patients with chronic stable angina.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d2261ee",
      "audio": ""
    },
    {
      "text": "A 78-year-old man with a history of hypertension and CAD presents with recurrent atrial flutter. He is on dabigatran, metoprolol, ramipril, aspirin, and atorvastatin. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cardiac catheterization",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cardioversion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Catheter ablation",
          "correct": true
        }
      ],
      "correct_answer": "D. Catheter ablation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Amiodarone : Antiarrhythmic drug with potential for toxicity, not the first-line treatment.</li><li>\u2022 Option A. Amiodarone</li><li>\u2022 Option B. Cardiac catheterization : Not needed for treating atrial flutter at this point.</li><li>\u2022 Option B. Cardiac catheterization</li><li>\u2022 Option C. Cardioversion : May provide temporary relief but is not definitive treatment in this case where the patient is experiencing recurrence.</li><li>\u2022 Option C. Cardioversion</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Catheter ablation is the best treatment for recurrent typical atrial flutter.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3acfdd9f",
      "audio": ""
    },
    {
      "text": "A 75-year-old woman with ischemic cardiomyopathy presents with progressive dyspnea, edema and confusion. Her medications include low-dose aspirin, furosemide, carvedilol, ramipril, digoxin, and spironolactone. Her BP is 84/52 mm Hg, PR is 118/min, RR is 28/min and SpO2 is 95 in room air. Her reports are shown below. ALT - 172 U/L, AST - 163 U/L, S. Creatinine - 2.9 mg/dL , S. K - 4.7 mEq/L, S. Na - 132 mEq/L & S. Digoxin - 0.3 ng/mL. What is the most appropriate initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Increase carvedilol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase digoxin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase lisinopril",
          "correct": false
        },
        {
          "label": "D",
          "text": "Start Noradrenaline",
          "correct": true
        }
      ],
      "correct_answer": "D. Start Noradrenaline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increase carvedilol : Beta-blockers are contraindicated in cardiogenic shock.</li><li>\u2022 Option A. Increase carvedilol</li><li>\u2022 Option B. Increase digoxin : Not effective in cardiogenic shock and potentially harmful with AKI.</li><li>\u2022 Option B. Increase digoxin</li><li>\u2022 Option C. Increase lisinopril : Afterload reduction may be considered later, but inotropic support is the priority in this patient with cardiogenic shock.</li><li>\u2022 Option C. Increase lisinopril</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 In patients with cardiogenic shock, inotropes such as Noradrenaline, dobutamine or milrinone may be considered to improve cardiac function.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "78a82400",
      "audio": ""
    },
    {
      "text": "A 75-year-old asymptomatic woman with CAD, diabetes and hypertension presents with palpitations. ECG shows AF. She is on metoprolol, telmisartan, aspirin, and atorvastatin. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Add clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Add oral anticoagulation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discontinue aspirin and begin oral anticoagulation",
          "correct": true
        },
        {
          "label": "D",
          "text": "No change in therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Discontinue aspirin and begin oral anticoagulation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adding clopidogrel : Not indicated, as the patient has no recent ACS or stent.</li><li>\u2022 Option A. Adding clopidogrel</li><li>\u2022 Option B. Adding oral anticoagulation without discontinuing aspirin : Increases bleeding risk.</li><li>\u2022 Option B. Adding oral anticoagulation without discontinuing aspirin</li><li>\u2022 Option D. No change in therapy : Inadequate as the patient needs anticoagulation for stroke prevention.</li><li>\u2022 Option D. No change in therapy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 For most patients with high-risk atrial fibrillation and stable coronary artery disease, oral anticoagulation therapy without an antiplatelet agent is sufficient for prevention of both acute coronary syndromes and thromboembolism.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d1cf12a",
      "audio": ""
    },
    {
      "text": "A 64-year-old man with a history of peripheral artery disease (PAD) presents with acute right leg pain. On examination, the right foot is cool and pedal pulses are absent. Sensation and muscle strength are normal. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Arterial duplex ultrasonography",
          "correct": false
        },
        {
          "label": "B",
          "text": "CT angiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Emergent right leg amputation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Initiate Heparin",
          "correct": true
        }
      ],
      "correct_answer": "D. Initiate Heparin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Arterial duplex ultrasonography: While useful for diagnosing PAD, it is not the immediate priority in acute limb ischemia. Revascularization should be initiated before obtaining imaging studies.</li><li>\u2022 Option A. Arterial duplex ultrasonography:</li><li>\u2022 Option B. CT angiography: This can provide a detailed view of the arterial anatomy and identify the location of the occlusion, but it should not delay revascularization.</li><li>\u2022 Option B. CT angiography:</li><li>\u2022 Option C. Emergent right leg amputation: This is a last resort if revascularization fails or is not possible. Amputation should not be considered until all revascularization options have been exhausted.</li><li>\u2022 Option C. Emergent right leg amputation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Prompt initiation of anticoagulation with heparin in ALI to prevent further thrombus formation and limb loss.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "50f7079d",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with diabetes and PAD has a right foot ulcer and feeble pulses. Ankle Brachial Index (ABI) on the right is 1.65. What is the next step?",
      "options": [
        {
          "label": "A",
          "text": "Exercise ankle-brachial index (ABI)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lower extremity CT angiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Toe-brachial index (TBI)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Venous duplex ultrasonography",
          "correct": false
        }
      ],
      "correct_answer": "C. Toe-brachial index (TBI)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Exercise ABI : Not useful when resting ABI is uninterpretable.</li><li>\u2022 Option A. Exercise ABI</li><li>\u2022 Option B. Lower Extremity CT angiography : Helpful for planning revascularization, but TBI is the more appropriate initial test in this scenario.</li><li>\u2022 Option B. Lower Extremity CT angiography</li><li>\u2022 Option D. Venous duplex ultrasonography : Evaluates for venous disease, not arterial.</li><li>\u2022 Option D. Venous duplex ultrasonography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Toe-brachial index (TBI) is useful in diagnosing PAD when ankle-brachial index (ABI) is uninterpretable due to non-compressible vessels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d841d436",
      "audio": ""
    },
    {
      "text": "52-year-old woman complains of chest tightness after walking for 2-3 km and relieved with rest. Her resting ECG is normal. She is known case of hypertension and dyslipidemia and currently taking ramipril and atorvastatin. What is the most appropriate diagnostic test?",
      "options": [
        {
          "label": "A",
          "text": "Adenosine single-photon emission CT",
          "correct": false
        },
        {
          "label": "B",
          "text": "Coronary artery calcium scoring",
          "correct": false
        },
        {
          "label": "C",
          "text": "Exercise electrocardiography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stress echocardiography",
          "correct": false
        }
      ],
      "correct_answer": "C. Exercise electrocardiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adenosine single-photon emission CT : Reserved for patients who cannot exercise or have uninterpretable ECGs.</li><li>\u2022 Option A. Adenosine single-photon emission CT</li><li>\u2022 Option B. Coronary artery calcium scoring : Used for risk stratification in asymptomatic patients especially to know the need for a statin. The patient is already on atorvastatin.</li><li>\u2022 Option B. Coronary artery calcium scoring</li><li>\u2022 Option D. Stress echocardiography : Can be considered if exercise ECG is inconclusive.</li><li>\u2022 Option D. Stress echocardiography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Exercise ECG is the first-line test for evaluating suspected CAD in patients with typical angina and a normal resting ECG.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6efe450b",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with ischemic cardiomyopathy (EF 20%) and NYHA class III heart failure is on maximally tolerated doses of ACE inhibitor, furosemide, and empagliflozin. ECG shows LBBB with a QRS duration of 130 ms. What is the most appropriate additional treatment?",
      "options": [
        {
          "label": "A",
          "text": "Add carvedilol",
          "correct": true
        },
        {
          "label": "B",
          "text": "Add ivabradine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Add digoxin",
          "correct": false
        },
        {
          "label": "D",
          "text": "CRT-D",
          "correct": false
        }
      ],
      "correct_answer": "A. Add carvedilol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Add Ivabradine : Indicated only after maximally tolerated beta-blocker dose.</li><li>\u2022 Option B. Add Ivabradine</li><li>\u2022 Option D. CRT-D : Considered if LVEF remains \u226435%, QRS duration \u2265150 ms, and NYHA class II-IV symptoms despite optimal medical therapy.</li><li>\u2022 Option D. CRT-D</li><li>\u2022 Option C. Add digoxin : Considered for primary prevention of sudden cardiac death in patients with LVEF \u226435% despite optimal medical therapy.</li><li>\u2022 Option C.</li><li>\u2022 Add digoxin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Initiate beta-blocker therapy in patients with HFrEF who are not already on it, as part of guideline-directed medical therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5193c110",
      "audio": ""
    },
    {
      "text": "A 64-year-old woman presents with acute type B aortic dissection involving the descending thoracic aorta with a maximal aortic diameter of 6.8 cm. Her BP is 173/99 mm Hg and PR is 90/min. What is the most appropriate initial management?",
      "options": [
        {
          "label": "A",
          "text": "Immediate endovascular stenting",
          "correct": false
        },
        {
          "label": "B",
          "text": "Immediate open surgical repair",
          "correct": false
        },
        {
          "label": "C",
          "text": "IV labetalol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Repeat CT angiography in 12 hours",
          "correct": false
        }
      ],
      "correct_answer": "C. IV labetalol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Immediate endovascular stenting: Endovascular stenting can be used to treat patients with descending aortic aneurysms; however, there is scant evidence to support this as an initial treatment option for aneurysm with dissection. After medical stabilization, thoracic endovascular aortic repair (TEVAR) with stent grafting can be used; typical indications include descending aortic aneurysm diameter greater than 6.0 cm, rapid growth (>0.5 cm/year), or end-organ damage. TEVAR has the advantage over surgical operation of lower morbidity and shorter hospital stay, although there may be complications, including stroke, spinal ischemia, and aortic graft endoleaks. This patient should be treated with stent implantation only after medical stabilization.</li><li>\u2022 Option A. Immediate endovascular stenting:</li><li>\u2022 Option B. Immediate open surgical repair: Open surgical repair of the descending aorta is not recommended in patients with uncomplicated type B aortic dissection because of high rates of morbidity (such as paraplegia) and mortality. This patient has no signs or symptoms of complications that would prompt immediate surgical repair.</li><li>\u2022 Option B. Immediate open surgical repair:</li><li>\u2022 Option D. Repeat CT angiography in 12 hours: Repeat CT angiography at 12 hours is not indicated unless the patient does not stabilize with medical therapy. Serial imaging (usually magnetic resonance angiography) is typically performed in asymptomatic patients at the time of discharge and then periodically in patients who do not have an indication for aneurysmal repair to screen for extension or recurrence of the dissection, aneurysm formation, and leakage.</li><li>\u2022 Option D. Repeat CT angiography in 12 hours:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Patients with uncomplicated type B aortic dissection may be initially treated with medical therapy, including \u03b2-blockers, sodium nitroprusside, and opioids.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7b42022",
      "audio": ""
    },
    {
      "text": "An 81-year-old woman had a drug-eluting stent (DES) for chronic stable angina 1 month ago. She is currently on aspirin and clopidogrel. She is a known case of hypertension, dyslipidaemia, CKD and peptic ulcer disease and was on medications for the same. She wants to minimize DAPT in view of her age and comorbidities. How long should she continue DAPT?",
      "options": [
        {
          "label": "A",
          "text": "Discontinue clopidogrel now",
          "correct": false
        },
        {
          "label": "B",
          "text": "Discontinue clopidogrel in 5 months",
          "correct": true
        },
        {
          "label": "C",
          "text": "Discontinue clopidogrel in 11 months",
          "correct": false
        },
        {
          "label": "D",
          "text": "Discontinue clopidogrel and aspirin in 11 months",
          "correct": false
        }
      ],
      "correct_answer": "B. Discontinue clopidogrel in 5 months",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Discontinuing clopidogrel in 1 month can be done in case of bare metal stents (BMS) and not DES.</li><li>\u2022 Option A.</li><li>\u2022 Option C. 12 months of DAPT is recommended in patient with ACS.</li><li>\u2022 Option C.</li><li>\u2022 Option D . Aspirin should be continued indefinitely in patients with CAD.</li><li>\u2022 Option D</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Dual antiplatelet therapy is recommended for at least 6 months after drug-eluting stent placement for treatment of stable angina.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f947784e",
      "audio": ""
    },
    {
      "text": "A 40-year-old male with recent post-CABG (coronary artery bypass graft) status presents with chest pain. On arrival, his blood pressure is 60/30 mmHg with a heart rate of 30/min. The ECG shows a narrow complex arrhythmia. The patient has already received three boluses of IV atropine. While awaiting transcutaneous pacing, which of the following is the next appropriate step in management?",
      "options": [
        {
          "label": "A",
          "text": "Another bolus of atropine",
          "correct": false
        },
        {
          "label": "B",
          "text": "IV Norepinephrine",
          "correct": false
        },
        {
          "label": "C",
          "text": "IV Dopamine",
          "correct": true
        },
        {
          "label": "D",
          "text": "IV Dobutamine",
          "correct": false
        }
      ],
      "correct_answer": "C. IV Dopamine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Another bolus of atropine: As per ACLS guidelines, a maximum of three boluses of atropine are recommended for symptomatic bradycardia. Further doses are unlikely to be effective.</li><li>\u2022 Option A. Another bolus of atropine:</li><li>\u2022 Option B. IV Norepinephrine: While norepinephrine is a potent vasopressor, it can also worsen bradycardia due to its reflex bradycardia effect (baroreceptor response).</li><li>\u2022 Option B. IV Norepinephrine:</li><li>\u2022 Opion D. IV Dobutamine: Dobutamine primarily acts on beta-1 receptors, increasing heart rate and contractility, but it can also cause vasodilation (beta-2 effects), potentially worsening hypotension.</li><li>\u2022 Opion D. IV Dobutamine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Chronotropic drugs like dopamine can be tried while awaiting pacing in symptomatic bradycardia with hypotension, especially when atropine has been ineffective.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "334e0e3b",
      "audio": ""
    },
    {
      "text": "Which of the following non-invasive tests has the best accuracy in detecting coronary stenosis?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac magnetic resonance perfusion scan",
          "correct": false
        },
        {
          "label": "B",
          "text": "Coronary CT angiography",
          "correct": true
        },
        {
          "label": "C",
          "text": "SPECT MPI",
          "correct": false
        },
        {
          "label": "D",
          "text": "Exercise echocardiography",
          "correct": false
        }
      ],
      "correct_answer": "B. Coronary CT angiography",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-091702.png"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. CMR perfusion have high sensitivity, but their specificity is not as high as Coronary CTA, meaning they might produce more false-positive results.</li><li>\u2022 Option A. CMR perfusion</li><li>\u2022 Option D. Exercise echocardiography and Option C. SPECT MPI have lower sensitivity and specificity than Coronary CTA, indicating a higher chance of both false negatives and false positives.</li><li>\u2022 Option D. Exercise echocardiography</li><li>\u2022 Option</li><li>\u2022 C. SPECT MPI</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Coronary CTA is a highly accurate non-invasive test for detecting coronary stenosis due to its excellent sensitivity and specificity. It is a valuable tool for diagnosing and evaluating CAD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f67c218",
      "audio": ""
    },
    {
      "text": "Mr. Xavier, a 72-year-old retired judge, experiences increased fatigue during walking. His physical exam, vitals, baseline ECG and 2D Echo are normal. Exercise ECG shows a peak heart rate of 96 beats/min with no ST changes. What is the most likely cause of his symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Chronotropic incompetence",
          "correct": true
        },
        {
          "label": "B",
          "text": "HFpEF",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lung disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Normal aging",
          "correct": false
        }
      ],
      "correct_answer": "A. Chronotropic incompetence",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. HFpEF : Unlikely given the normal echocardiogram, especially the normal atrial size.</li><li>\u2022 Option B. HFpEF</li><li>\u2022 Option C. Lung disease : Unlikely given the normal chest X-ray and absence of respiratory symptoms.</li><li>\u2022 Option C. Lung disease</li><li>\u2022 Option D. Normal aging : While aging can cause some decline in exercise tolerance, this patient's significant fatigue suggests a pathological cause.</li><li>\u2022 Option D. Normal aging</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Predicted maximal HR \u223c 220-Age</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8ea9b880",
      "audio": ""
    },
    {
      "text": "Mr. Venkatesh, a 40-year-old man with hypertension treated with hydrochlorothiazide and metoprolol, presents with fatigue. His physical exam is normal except for a heart rate of 40 beats/min. ECG shows sinus bradycardia. Lab tests, including thyroid function and hemoglobin, are normal. What is the most reasonable next step?",
      "options": [
        {
          "label": "A",
          "text": "Dual-chamber pacemaker implantation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Exercise ECG test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Start isoprenaline 10mg TID",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stop metoprolol",
          "correct": true
        }
      ],
      "correct_answer": "D. Stop metoprolol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Dual chamber Pacemaker implantation : This may be indicated later if the bradycardia persists or is symptomatic after discontinuing the beta-blocker.</li><li>\u2022 Option A. Dual chamber Pacemaker implantation</li><li>\u2022 Option B. Exercise ECG test : This may be helpful to assess the chronotropic response, but the priority is to address the potential medication-induced bradycardia first.</li><li>\u2022 Option B. Exercise ECG test</li><li>\u2022 Option C. Start isoprenaline 10mg TID : This is a pure beta agonist with chronotropic effects and is not a first-line treatment for bradycardia.</li><li>\u2022 Option C. Start isoprenaline 10mg TID</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Beta blockers and calcium channel blockers increase sinus node recovery time and can cause severe sinus bradycardia in some individuals.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c1265e0b",
      "audio": ""
    },
    {
      "text": "A 46-year-old man with bacterial pneumonia experiences a sudden lightheadedness. His BP is stable, and the rhythm strip is shown. Which of the following is most likely to lead to sustained improvement in heart rate?",
      "options": [
        {
          "label": "A",
          "text": "Adenosine 6 mg IV",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carotid body massage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metoprolol 5 mg IV",
          "correct": true
        },
        {
          "label": "D",
          "text": "Valsalva maneuver",
          "correct": false
        }
      ],
      "correct_answer": "C. Metoprolol 5 mg IV",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-182921.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adenosine 6 mg IV : Primarily used for supraventricular tachycardia (SVT) and may not be effective in FAT.</li><li>\u2022 Option A. Adenosine 6 mg IV</li><li>\u2022 Option B. Carotid body massage : A vagal maneuver that may temporarily slow the heart rate but is not a definitive treatment.</li><li>\u2022 Option B. Carotid body massage</li><li>\u2022 Option D. Valsalva maneuver : A vagal maneuver that may temporarily slow the heart rate but is not a definitive treatment.</li><li>\u2022 Option D. Valsalva maneuver</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Focal atrial tachycardia is not dependent on the AV node and beta-blockers or non-dihydropyridine CCBs are the preferred treatment options for rate control.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "adfe0a42",
      "audio": ""
    },
    {
      "text": "You are called to the ER for a young patient in cardiac arrest during exercise. ECG showed bidirectional VT and it was cardioverted immediately. ECG post-cardioversion is normal. 2D Echo and cardiac MRI are also normal. Mutations in which protein are responsible for this?",
      "options": [
        {
          "label": "A",
          "text": "Calcium ryanodine receptor",
          "correct": true
        },
        {
          "label": "B",
          "text": "Desmosomal proteins",
          "correct": false
        },
        {
          "label": "C",
          "text": "Potassium channel",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sarcomere proteins",
          "correct": false
        }
      ],
      "correct_answer": "A. Calcium ryanodine receptor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Desmosomal proteins: Mutations in desmosomal proteins cause arrhythmogenic right ventricular cardiomyopathy (ARVC), which is a structural heart disease.</li><li>\u2022 Option B. Desmosomal proteins:</li><li>\u2022 Option C. Potassium channel: Mutations in potassium channels can cause long QT syndrome. In this case resting ECG would have showed long QTc.</li><li>\u2022 Option C. Potassium channel:</li><li>\u2022 Option D. Sarcomere proteins: Mutations in sarcomere proteins cause hypertrophic cardiomyopathy (HCM), which would have resulted in structural heart disease.</li><li>\u2022 Option D. Sarcomere proteins:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognize bidirectional VT as a hallmark of CPVT, an inherited arrhythmia syndrome caused by mutations in the cardiac ryanodine receptor (RyR2).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5f9fa051",
      "audio": ""
    },
    {
      "text": "Mr. Vadivel, a 5-year post-heart transplant patient with no prior rejection episodes, presents with progressive exertional dyspnea and chest discomfort. He is on tacrolimus, mycophenolate mofetil, and low-dose prednisolone. 2D Echo shows normal LV function and no valvular abnormalities. What is the most likely cause of his symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Antibody-mediated rejection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cellular rejection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coronary artery disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Endocarditis",
          "correct": false
        }
      ],
      "correct_answer": "C. Coronary artery disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Antibody-mediated rejection : Rare this far out from transplant, especially without prior rejection.</li><li>\u2022 Option A. Antibody-mediated rejection</li><li>\u2022 Option B. Cellular rejection : Unlikely with normal LV function and no arrhythmias.</li><li>\u2022 Option B. Cellular rejection</li><li>\u2022 Option D. Endocarditis : Less likely without fever or new murmur.</li><li>\u2022 Option D. Endocarditis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognize that coronary artery disease is a major cause of late mortality in heart transplant recipients, even in the absence of typical risk factors or angina.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ea1719e2",
      "audio": ""
    },
    {
      "text": "Cardiac allograft vasculopathy (CAV) is different from atherosclerotic CAD. Which of the following regarding CAV is false?",
      "options": [
        {
          "label": "A",
          "text": "Eccentric lesions",
          "correct": true
        },
        {
          "label": "B",
          "text": "Minimal calcification",
          "correct": false
        },
        {
          "label": "C",
          "text": "Poor collaterals",
          "correct": false
        },
        {
          "label": "D",
          "text": "Microvasculature affected",
          "correct": false
        }
      ],
      "correct_answer": "A. Eccentric lesions",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-183458.png"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option B. Minimal calcification: CAV lesions often have minimal calcification, particularly in the early stages, which can make them difficult to detect on standard coronary angiography.</li><li>\u2022 Option B. Minimal calcification:</li><li>\u2022 Option C. Poor collaterals: The development of collateral vessels is often impaired in CAV, making the heart more vulnerable to ischemia and infarction.</li><li>\u2022 Option C. Poor collaterals:</li><li>\u2022 Option d. Microvasculature affected: CAV can affect both the epicardial coronary arteries and the microvasculature, leading to diffuse myocardial dysfunction.</li><li>\u2022 Option</li><li>\u2022 d. Microvasculature affected:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 CAV is different from CAD and difficult to treat.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6c3f5c33",
      "audio": ""
    },
    {
      "text": "A 67-year-old man with a history of hypertension and hyperlipidemia presents with severe chest pain. His ECG shows ST-segment depression and his initial troponin level is elevated. He is currently taking aspirin, amlodipine, simvastatin, and tadalafil. Which of the following medications should NOT be administered?",
      "options": [
        {
          "label": "A",
          "text": "Clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Heparin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metoprolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nitroglycerin",
          "correct": true
        }
      ],
      "correct_answer": "D. Nitroglycerin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Clopidogrel : P2Y12 inhibitor, indicated in NSTEMI.</li><li>\u2022 Option A. Clopidogrel</li><li>\u2022 Option B. Heparin IV : Anticoagulation, indicated in NSTEMI.</li><li>\u2022 Option B. Heparin IV</li><li>\u2022 Option C. Metoprolol IV : Beta-blocker, indicated in NSTEMI unless contraindicated (e.g., heart failure).</li><li>\u2022 Option C. Metoprolol IV</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Be aware of the contraindication of nitroglycerin in patients taking phosphodiesterase-5 inhibitors due to the risk of severe hypotension.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "58fb060b",
      "audio": ""
    },
    {
      "text": "You are seeing a 75-year-old man admitted for non-ST-elevation myocardial infarction. He has a history of CAD and takes daily aspirin. He's had multiple angina episodes in the past few days, has ST-segment depression on ECG, and elevated troponin. Which of the following details does NOT confer increased risk of poor outcomes?",
      "options": [
        {
          "label": "A",
          "text": "Two anginal episode in 24 hours.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Age.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Daily aspirin use.",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above confer increased risk.",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above confer increased risk.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Two anginal episode in 24 hours : High risk indicating loss of ischemic preconditioning and an active/ongoing ischemia.</li><li>\u2022 Option A. Two anginal episode in 24 hours</li><li>\u2022 Option B. Age : Advanced age is the SINGLE most important risk factor in ACS.</li><li>\u2022 Option B. Age</li><li>\u2022 Option C. Daily aspirin use : While aspirin is cardioprotective, ACS despite use of aspirin indicates high thrombus burden and hence, high risk.</li><li>\u2022 Option C. Daily aspirin use</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 TIMI score for NSTE-ACS is important!</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "732b13e2",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman experiences recurrent chest pain with transient ST elevations during episodes. Angiography shows normal coronary arteries, but pain is worse during hyperventilation. Which of the following is NOT a reasonable treatment for her condition?",
      "options": [
        {
          "label": "A",
          "text": "Amlodipine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aspirin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Long-acting oral nitrates",
          "correct": false
        },
        {
          "label": "D",
          "text": "Diltiazem",
          "correct": false
        }
      ],
      "correct_answer": "B. Aspirin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Amlodipine & Option D. Diltiazem (calcium channel blockers): These relax the smooth muscle in the coronary arteries, preventing or reversing vasospasm.</li><li>\u2022 Option A. Amlodipine & Option D. Diltiazem</li><li>\u2022 Option C. Long-acting oral nitrates: These medications help to dilate the coronary arteries and reduce the frequency of vasospastic episodes.</li><li>\u2022 Option C. Long-acting oral nitrates:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Aspirin is C/I in Prinzmetal's angina due to its potential to worsen vasospasm.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4b74e386",
      "audio": ""
    },
    {
      "text": "Mr. Sengutuvel, a 57-year-old man with risk factors for CAD, presents with crushing chest pain, diaphoresis, and shortness of breath. Which diagnostic test will most rapidly guide therapeutic management?",
      "options": [
        {
          "label": "A",
          "text": "ECG",
          "correct": true
        },
        {
          "label": "B",
          "text": "Coronary CT Angiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Echocardiogram",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serum troponin I level",
          "correct": false
        }
      ],
      "correct_answer": "A. ECG",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-184050.png"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Coronary CT angiography : Coronary CT angiography is not warranted in a patient having active ischemic pain.</li><li>\u2022 Option B. Coronary CT angiography</li><li>\u2022 Option C. Echocardiogram : Can show wall motion abnormalities but cannot differentiate between STEMI and NSTEMI.</li><li>\u2022 Option C. Echocardiogram</li><li>\u2022 Option D. Serum troponin I level : A key biomarker for MI, but it takes time to elevate, and ECG is crucial for immediate decision-making.</li><li>\u2022 Option D. Serum troponin I level</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients with suspected ACS, a 12-lead ECG is the most rapid and crucial test to guide immediate management decisions, especially regarding the need for urgent reperfusion therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c61253e2",
      "audio": ""
    },
    {
      "text": "A 74-year-old man with a history of smoking presents with progressive bilateral calf pain that worsens with walking and improves with rest. He has normal resting ankle-brachial index (ABI) values. What is the most appropriate next test?",
      "options": [
        {
          "label": "A",
          "text": "Exercise ankle-brachial index (ABI) testing",
          "correct": true
        },
        {
          "label": "B",
          "text": "Invasive angiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Magnetic resonance angiography (MRA)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Segmental lower extremity blood pressure testing",
          "correct": false
        }
      ],
      "correct_answer": "A. Exercise ankle-brachial index (ABI) testing",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Invasive angiography : Not the initial test, reserved for patients with severe PAD or when revascularization is planned.</li><li>\u2022 Option B. Invasive angiography</li><li>\u2022 Option C. MRA : Another option for anatomic imaging, but exercise ABI is a less invasive first step.</li><li>\u2022 Option C. MRA</li><li>\u2022 Option D. Segmental lower extremity blood pressure testing : Used to localize PAD, but not necessary as the initial test when the ABI is normal.</li><li>\u2022 Option D. Segmental lower extremity blood pressure testing</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 25% of patients with typical claudication symptoms have a normal or borderline ankle-brachial index.</li><li>\u27a4 Exercise ABI testing is useful to evaluate for peripheral artery disease in patients with normal ABI values (>0.90 and \u22641.40) and high suspicion of PAD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d56515ae",
      "audio": ""
    },
    {
      "text": "A 68-year-old man is evaluated one month after atherectomy and stenting of the right superficial femoral artery for severe claudication. He is now asymptomatic and on guideline-directed medical therapy (GDMT) for peripheral artery disease (PAD). Lab results show total cholesterol 120 mg/dL, LDL 50 mg/dL, and HDL 48 mg/dL. What is the most appropriate additional treatment?",
      "options": [
        {
          "label": "A",
          "text": "Cilostazol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Evolocumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ticagrelor",
          "correct": false
        },
        {
          "label": "D",
          "text": "No additional treatment",
          "correct": true
        }
      ],
      "correct_answer": "D. No additional treatment",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cilostazol : Used to improve walking distance in patients with claudication, but not necessary for asymptomatic patients.</li><li>\u2022 Option A. Cilostazol</li><li>\u2022 Option B. Evolocumab : A PCSK9 inhibitor used to further lower LDL cholesterol in high-risk patients. Not indicated in this patient with well-controlled LDL.</li><li>\u2022 Option B. Evolocumab</li><li>\u2022 Option C. Ticagrelor : A more potent antiplatelet agent, not routinely recommended for PAD in addition to aspirin. May be added in high risk PAD (e.g., if associated CAD).</li><li>\u2022 Option C. Ticagrelor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Guideline-directed medical therapy for peripheral artery disease includes exercise; an antiplatelet agent; and aggressive management of atherosclerotic risk factors, including smoking, hypertension, diabetes mellitus, and dyslipidemia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "824ffab0",
      "audio": ""
    },
    {
      "text": "A 45-year-old man with hyperlipidemia, prediabetes, and a significant smoking history is seeking cardiovascular risk reduction. Which intervention is most likely to have the greatest impact on his risk?",
      "options": [
        {
          "label": "A",
          "text": "Depression screening and treatment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Low-dose aspirin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Smoking cessation counseling and varenicline",
          "correct": true
        },
        {
          "label": "D",
          "text": "Weight loss",
          "correct": false
        }
      ],
      "correct_answer": "C. Smoking cessation counseling and varenicline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Depression screening and treatment : Important, but smoking cessation has a more immediate and significant impact on cardiovascular risk.</li><li>\u2022 Option A. Depression screening and treatment</li><li>\u2022 Option B. Low-dose aspirin : Controversial and not routinely recommended for primary prevention in this scenario.</li><li>\u2022 Option B. Low-dose aspirin</li><li>\u2022 Option D. Weight loss : Beneficial for cardiovascular health but less impactful than smoking cessation.</li><li>\u2022 Option D. Weight loss</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Smoking cessation substantially reduces cardiovascular risk within 2 years, with risk returning to the level of a nonsmoker after \u223c 15 years.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d181dc4b",
      "audio": ""
    },
    {
      "text": "A 75-year-old man with a history of atrial fibrillation, diabetes, and peripheral artery disease presents with acute left leg pain, absent pulses, and cold, mottled skin. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Angiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Apixaban",
          "correct": false
        },
        {
          "label": "C",
          "text": "Unfractionated heparin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Venous duplex ultrasonography",
          "correct": false
        }
      ],
      "correct_answer": "C. Unfractionated heparin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Angiography: Essential for diagnosis and planning revascularization, but anticoagulation should be started first.</li><li>\u2022 Option A. Angiography:</li><li>\u2022 Option B. Apixaban : Oral anticoagulant, not appropriate in the acute setting of ALI.</li><li>\u2022 Option B. Apixaban</li><li>\u2022 Option D. Venous duplex ultrasonography : Not indicated for ALI, which is an arterial problem.</li><li>\u2022 Option D. Venous duplex ultrasonography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Treat acute limb ischemia with anticoagulation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9c1e1a5",
      "audio": ""
    },
    {
      "text": "A 74-year-old man with peripheral artery disease (PAD) was prescribed atorvastatin. He has read in a newspaper that statins can cause muscle aches and stopped taking atorvastatin after he developed worsening leg pain upon walking. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Atorvastatin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Colestipol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ezetimibe",
          "correct": false
        },
        {
          "label": "D",
          "text": "Icosapent ethyl",
          "correct": false
        }
      ],
      "correct_answer": "A. Atorvastatin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Colestipol (bile acid resin): Not a first-line agent for PAD.</li><li>\u2022 Option B. Colestipol</li><li>\u2022 Option C. Ezetimibe (cholesterol absorption inhibitor): Monotherapy with ezetimibe is NOT a substitute for statin therapy. Can be used as an add on if LDL-C is not adequately reduced.</li><li>\u2022 Option C. Ezetimibe</li><li>\u2022 Option D. Icosapent ethyl (fish oil): Used for triglyceride lowering, which may be considered in addition to statins to lower CV risk (in patients with triglycerides of 135-499 mg/dL).</li><li>\u2022 Option D. Icosapent ethyl</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Peripheral artery disease is considered a clinical atherosclerotic cardiovascular disease.</li><li>\u27a4 Statin therapy is recommended for secondary prevention of atherosclerotic cardiovascular disease in patients with peripheral artery disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bc62d83f",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with a recent non-ST-elevation myocardial infarction (NSTEMI) and peripheral artery disease (PAD) is on dual antiplatelet therapy (DAPT), an ACE inhibitor, a statin, and a beta-blocker. He is asymptomatic. His resting ankle-brachial index (ABI) is low bilaterally. What is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Exercise ABI testing",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lower extremity CT angiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Toe-brachial index testing",
          "correct": false
        },
        {
          "label": "D",
          "text": "No additional testing",
          "correct": true
        }
      ],
      "correct_answer": "D. No additional testing",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Exercise ABI testing : Indicated for symptomatic patients with normal or borderline resting ABI.</li><li>\u2022 Option A. Exercise ABI testing</li><li>\u2022 Option B. Lower extremity CT angiography : Considered if revascularization is planned.</li><li>\u2022 Option B. Lower extremity CT angiography</li><li>\u2022 Option C. Toe-brachial index testing : Used when ABI is unreliable due to non-compressible arteries.</li><li>\u2022 Option C. Toe-brachial index testing</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The American College of Cardiology recommends resting ankle-brachial index testing in patients with history or physical examination findings suggestive of peripheral artery disease.</li><li>\u27a4 Patients with both coronary artery disease and peripheral artery disease are at higher risk for major adverse cardiovascular events.</li><li>\u27a4 Also, avoid unnecessary testing in a patient with asymptomatic peripheral artery disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e351ba56",
      "audio": ""
    },
    {
      "text": "A 56-year-old man with a history of hypertension, hyperlipidemia, and CAD presents with a 3-month history of progressive left calf discomfort exacerbated by walking stairs but absent at rest. He is a smoker and he is currently on aspirin, rosuvastatin, metoprolol, and amlodipine. His left ABI is 0.68. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "CT angiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pentoxifylline",
          "correct": false
        },
        {
          "label": "C",
          "text": "Revascularization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Supervised exercise training",
          "correct": true
        }
      ],
      "correct_answer": "D. Supervised exercise training",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. CT angiography : While CT angiography is used for diagnosis and pre-procedural planning in PAD, it is not the first-line treatment for claudication.</li><li>\u2022 Option A. CT angiography</li><li>\u2022 Option B. Pentoxifylline : Not recommended for PAD treatment as it lacks evidence of benefit.</li><li>\u2022 Option B. Pentoxifylline</li><li>\u2022 Option C. Revascularization : Revascularization (either surgical or endovascular) may be considered if symptoms are refractory to exercise and medical therapy. However, it's not the initial step in management.</li><li>\u2022 Option C. Revascularization</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Supervised exercise training is the most effective initial treatment to increase walking distance for patients with intermittent claudication due to PAD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e49337fa",
      "audio": ""
    },
    {
      "text": "A 78-year-old woman with peripheral artery disease (PAD) has persistent claudication despite supervised exercise and optimal medical therapy. Her current medications are aspirin, metformin, canagliflozin, cilostazol, atorvastatin, and olmesartan. CT angiogram reveals an 80% stenosis in the left iliac artery. What is the best treatment?",
      "options": [
        {
          "label": "A",
          "text": "Pentoxifylline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Revascularization",
          "correct": true
        },
        {
          "label": "C",
          "text": "Stop canagliflozin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Switch olmesartan to ramipril",
          "correct": false
        }
      ],
      "correct_answer": "B. Revascularization",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pentoxifylline : Not recommended for PAD treatment due to lack of efficacy.</li><li>\u2022 Option A. Pentoxifylline</li><li>\u2022 Option C. Stop canagliflozin : SGLT2 inhibitors should be used with caution in PAD but not discontinued unless there are specific complications.</li><li>\u2022 Option C. Stop canagliflozin</li><li>\u2022 Option D. Switching to a different antihypertensive : ACEi or ARBs can provide survival benefit in ASCVD but unlikely to significantly improve symptoms which is the priority in this case.</li><li>\u2022 Option D. Switching to a different antihypertensive</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "58f96808",
      "audio": ""
    },
    {
      "text": "A 58-year-old man is evaluated for right leg tiredness and cramping when walking 25 yards. His feet are shown following elevation (left) and during dependent positioning (right). Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Inferior vena cava thrombosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Livedo reticularis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peripheral artery disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Venous insufficiency",
          "correct": false
        }
      ],
      "correct_answer": "C. Peripheral artery disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-094723.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Diagnose peripheral artery disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e1226a57",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman presents with recurrent fevers, night sweats, weight loss, and a transient ischemic attack (TIA). ECG is normal and echo is shown in the video. CT head is normal as well. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Administer a direct oral anticoagulant (DOAC)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer intravenous thrombolytic therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Obtain blood cultures and begin empiric antibiotics",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urgent surgical excision",
          "correct": true
        }
      ],
      "correct_answer": "D. Urgent surgical excision",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. DOAC : Anticoagulation may be considered temporarily before surgery (or if the patient has atrial fibrillation) but is not definitive treatment in this patient.</li><li>\u2022 Option A. DOAC</li><li>\u2022 Option B. Thrombolytic therapy : Not indicated for TIA caused by a cardiac tumor.</li><li>\u2022 Option B. Thrombolytic therapy</li><li>\u2022 Option C. Blood cultures and antibiotics : Not appropriate for a cardiac myxoma.</li><li>\u2022 Option C. Blood cultures and antibiotics</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Patients with a myxoma may present with valvular occlusive symptoms, such as dyspnea and syncope; embolic phenomena, including stroke or transient ischemic events; and/or constitutional symptoms, such as fever, anorexia, and weight loss.</li><li>\u27a4 In patients with atrial myxoma and a central nervous system embolic event, urgent cardiac surgical evaluation and excision are indicated.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "080bc4dc",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman with normal blood pressure and no significant medical history has a lipid profile showing total cholesterol of 241 mg/dL, HDL of 49 mg/dL, LDL of 116 mg/dL, and triglycerides of 128 mg/dL. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Begin high-intensity statin therapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Begin high-intensity statin therapy and ezetimibe",
          "correct": false
        },
        {
          "label": "C",
          "text": "Calculate 10-year risk for ASCVD",
          "correct": true
        },
        {
          "label": "D",
          "text": "Repeat lipid profile while fasting",
          "correct": false
        }
      ],
      "correct_answer": "C. Calculate 10-year risk for ASCVD",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Begin high-intensity statin therapy and Option B. Begin high-intensity statin therapy and ezetimibe : Starting statin therapy (with or without ezetimibe) is premature without assessing risk.</li><li>\u2022 Option A. Begin high-intensity statin therapy</li><li>\u2022 Option B. Begin high-intensity statin therapy and ezetimibe</li><li>\u2022 Option D. Repeat lipid profile while fasting : While fasting lipid profile is preferred, the non-fasting results do not warrant immediate repeat testing before risk assessment.</li><li>\u2022 Option D. Repeat lipid profile while fasting</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Cardiovascular risk scores can be used to assess a patient's future risk for major cardiovascular events and to identify preventive interventions.</li><li>\u27a4 The American College of Cardiology/American Heart Association Pooled Cohort Equations are commonly used to calculate the 10-year risk for atherosclerotic cardiovascular disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "152cc121",
      "audio": ""
    },
    {
      "text": "A 57-year-old woman undergoes successful primary percutaneous coronary intervention (PCI) for an acute anterior STEMI and cardiogenic shock. Angiography reveals a 100% occlusion of mid LAD and a 70% stenosis of mid-right coronary artery (RCA). What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "PCI to LAD and RCA",
          "correct": false
        },
        {
          "label": "B",
          "text": "PCI to LAD",
          "correct": true
        },
        {
          "label": "C",
          "text": "PCI to RCA",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urgent CABG",
          "correct": false
        }
      ],
      "correct_answer": "B. PCI to LAD",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. PCI to LAD and RCA : While both lesions need to be addressed, the priority is to revascularize the culprit lesion (LAD) first to stabilize the patient.</li><li>\u2022 Option A. PCI to LAD and RCA</li><li>\u2022 Option C. PCI to RCA : The RCA is not the infarct-related artery and should not be prioritized over the LAD in this scenario.</li><li>\u2022 Option C. PCI to RCA</li><li>\u2022 Option D. Urgent CABG : CABG is an option for multivessel disease, but PCI of the culprit lesion is the immediate priority in a patient with cardiogenic shock.</li><li>\u2022 Option D. Urgent CABG</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In STEMI with cardiogenic shock, the immediate priority is to restore blood flow to the infarct-related artery with primary PCI. Non-culprit lesions can be addressed later in a staged procedure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6c3d05dc",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman 2 weeks postpartum presents with chest pain, ST-segment elevation in anterior leads, and elevated troponin. She has no risk factors for atherosclerosis. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Atherosclerotic plaque rupture",
          "correct": false
        },
        {
          "label": "B",
          "text": "Peripartum cardiomyopathy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Spontaneous coronary artery dissection (SCAD)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stress-induced (takotsubo) cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Spontaneous coronary artery dissection (SCAD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Atherosclerotic plaque rupture : Unlikely in a young woman with no risk factors.</li><li>\u2022 Option A. Atherosclerotic plaque rupture</li><li>\u2022 Option B. Peripartum cardiomyopathy : Presents with heart failure symptoms and global LV dysfunction, not ST-elevation.</li><li>\u2022 Option B. Peripartum cardiomyopathy</li><li>\u2022 Option D. Takotsubo cardiomyopathy : Typically triggered by stress, often presents with apical ballooning on echo. Common in post-menopausal women (not young women).</li><li>\u2022 Option D. Takotsubo cardiomyopathy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Spontaneous coronary artery dissection is the most common cause of pregnancy-associated myocardial infarction and occurs most commonly in the first month postpartum</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f22c69b6",
      "audio": ""
    },
    {
      "text": "A 73-year-old man presents with a 3-hour history of chest pain. His BP is 80/50 mmHg, HR is 120/min and has elevated JVP and clear lungs. ECG is shown. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Intra-aortic balloon pump placement",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous dobutamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intravenous 0.9% saline",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oral metoprolol",
          "correct": false
        }
      ],
      "correct_answer": "C. Intravenous 0.9% saline",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-101859.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Intra-aortic balloon pump : Indicated in cardiogenic shock with LV dysfunction, but not the first-line treatment for RV infarction.</li><li>\u2022 Option A. Intra-aortic balloon pump</li><li>\u2022 Option B. Intravenous dobutamine: Inotrope may be considered if fluids are ineffective, but not the initial management.</li><li>\u2022 Option B. Intravenous dobutamine:</li><li>\u2022 Option D. Oral metoprolol : Beta-blockers can worsen hypotension and should be avoided in RV infarction.</li><li>\u2022 Option D. Oral metoprolol</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 A patient with an inferior myocardial infarction with right ventricular involvement and hypotension should receive intravenous fluids.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8038430",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman 2 weeks postpartum presents with chest pain, ST-segment elevation in anterior leads, and elevated troponin. She has no risk factors for atherosclerosis. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Atherosclerotic plaque rupture",
          "correct": false
        },
        {
          "label": "B",
          "text": "Peripartum cardiomyopathy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Spontaneous coronary artery dissection (SCAD)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stress-induced (takotsubo) cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Spontaneous coronary artery dissection (SCAD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Atherosclerotic plaque rupture : Unlikely in a young woman with no risk factors.</li><li>\u2022 Option A. Atherosclerotic plaque rupture</li><li>\u2022 Option B. Peripartum cardiomyopathy : Presents with heart failure symptoms and global LV dysfunction, not ST-elevation.</li><li>\u2022 Option B. Peripartum cardiomyopathy</li><li>\u2022 Option D. Takotsubo cardiomyopathy : Typically triggered by stress, often presents with apical ballooning on echo. Common in post menopausal women (not young women).</li><li>\u2022 Option D. Takotsubo cardiomyopathy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Spontaneous coronary artery dissection is the most common cause of pregnancy-associated myocardial infarction and occurs most commonly in the first month postpartum</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f22c69b6",
      "audio": ""
    },
    {
      "text": "A 74-year-old man with a history of CABG presents with progressive fatigue, dyspnea, elevated jugular venous pressure with Kussmaul's sign, and a pericardial knock. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac tamponade",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic liver disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Constrictive pericarditis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Restrictive cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Constrictive pericarditis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cardiac tamponade : Would not present with Kussmaul's sign or pericardial knock.</li><li>\u2022 Option A. Cardiac tamponade</li><li>\u2022 Option B. Chronic liver disease : Can cause ascites and edema but not the other findings.</li><li>\u2022 Option B. Chronic liver disease</li><li>\u2022 Option D. Restrictive cardiomyopathy : Can mimic constrictive pericarditis, but the history of CABG makes the latter more likely.</li><li>\u2022 Option D. Restrictive cardiomyopathy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Kussmaul sign and pericardial knock, if present, are helpful clues to the presence of constrictive pericarditis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37fb2263",
      "audio": ""
    },
    {
      "text": "A 58-year-old man presents with an chest pain, nausea and diaphoresis. ECG is shown. The nearest tertiary care center is 140 minutes away. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "CT angiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thrombolysis and admission to a telemetry bed",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thrombolysis and transfer to a PCI center",
          "correct": true
        },
        {
          "label": "D",
          "text": "Transfer to a tertiary care center",
          "correct": false
        }
      ],
      "correct_answer": "C. Thrombolysis and transfer to a PCI center",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-102708.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. CT angiography : Delays reperfusion therapy, which is crucial in STEMI.</li><li>\u2022 Option A. CT angiography</li><li>\u2022 Option B. Thrombolyse and admit : Does not allow for timely angiography and potential rescue PCI.</li><li>\u2022 Option B. Thrombolyse and admit</li><li>\u2022 Option D. Transfer to tertiary care center : Delays reperfusion and worsens outcomes.</li><li>\u2022 Option D. Transfer to tertiary care center</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 For patients with STEMI, thrombolytic therapy is recommended if symptom onset is within 12 hours and PPCI is not available within 120 minutes of FMC.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2b83912",
      "audio": ""
    },
    {
      "text": "A 73-year-old woman presents with severe chest pain for the last 3 hours. She is diaphoretic and appears drowsy. Her BP is 80/60 mm Hg and PR is 60/min. ECG is shown below. She was started on aspirin, clopidogrel and heparin. What is the next step?",
      "options": [
        {
          "label": "A",
          "text": "Atropine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tenecteplase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Primary Angioplasty",
          "correct": false
        },
        {
          "label": "D",
          "text": "Temporary pacing",
          "correct": true
        }
      ],
      "correct_answer": "D. Temporary pacing",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-102907.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Atropine: Atropine may be useful for bradycardia but is unlikely to be effective in the setting of high-grade AV block. Additionally, it does not address the underlying myocardial ischemia.</li><li>\u2022 Option A. Atropine:</li><li>\u2022 Option B. Tenecteplase: While fibrinolysis with tenecteplase may be considered in some STEMI cases, it is not the first-line therapy in this case.</li><li>\u2022 Option B. Tenecteplase:</li><li>\u2022 Option C. Primary Angioplasty: Primary PCI is the preferred reperfusion strategy for STEMI, but it should be performed after stabilizing the patient's hemodynamics with temporary pacing.</li><li>\u2022 Option C. Primary Angioplasty:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Anterior MI related bradyarrhythmias are inherently unstable and need temporary pacing.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ea3e1ed",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with subacute pericarditis, fever, pulsus paradoxus, and pericardial friction rub. ECG shows diffuse ST-segment elevation. Echocardiogram shows a small pericardial effusion. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Discharge on ibuprofen and colchicine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Discharge on prednisone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hospitalize and begin ibuprofen and colchicine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hospitalize and begin methylprednisolone",
          "correct": false
        }
      ],
      "correct_answer": "C. Hospitalize and begin ibuprofen and colchicine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Outpatient treatment : Not appropriate for high-risk pericarditis.</li><li>\u2022 Option A. Outpatient treatment</li><li>\u2022 Option B. Prednisone : Reserved for recurrent or refractory pericarditis.</li><li>\u2022 Option B. Prednisone</li><li>\u2022 Option D. Methylprednisolone : High-dose steroids are not first-line for initial treatment.</li><li>\u2022 Option D. Methylprednisolone</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Hospitalize patients with acute pericarditis and high-risk features for initial treatment and monitoring.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7530678",
      "audio": ""
    },
    {
      "text": "A 71-year-old woman presents with cardiogenic shock. ECG showed ST depressions in multiple leads and her Troponins were elevated. PCI was performed successfully but she continues to be in cardiogenic shock and she is on aspirin, prasugrel and norepinephrine. Which of the following is the most appropriate additional management?",
      "options": [
        {
          "label": "A",
          "text": "Digoxin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intra-aortic balloon pump (IABP) placement",
          "correct": true
        },
        {
          "label": "C",
          "text": "Metoprolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urgent cardiac transplantation",
          "correct": false
        }
      ],
      "correct_answer": "B. Intra-aortic balloon pump (IABP) placement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Digoxin : Weak inotrope, unlikely to be effective in cardiogenic shock.</li><li>\u2022 Option A. Digoxin</li><li>\u2022 Option C. Metoprolol : Beta-blocker, contraindicated in cardiogenic shock due to negative inotropic effects.</li><li>\u2022 Option C. Metoprolol</li><li>\u2022 Option D. Urgent cardiac transplantation : Not feasible in the acute setting.</li><li>\u2022 Option D. Urgent cardiac transplantation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 IABP is a mechanical circulatory support device that can temporarily improve hemodynamics in patients with cardiogenic shock after MI by reducing afterload and improving coronary perfusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "75e4b913",
      "audio": ""
    },
    {
      "text": "A 77-year-old woman with COPD and prior stroke presents with intermittent chest pain. She is on aspirin, atorvastatin, MDI salbutamol and MDI tiotropium. ECG is taken and shown. Initial troponin is elevated and she was started on enoxaparin. What is the most appropriate additional treatment?",
      "options": [
        {
          "label": "A",
          "text": "Clopidogrel",
          "correct": true
        },
        {
          "label": "B",
          "text": "Prasugrel",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reteplase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tirofiban",
          "correct": false
        }
      ],
      "correct_answer": "A. Clopidogrel",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-105337.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Prasugrel : Absolutely C/I in patients with prior stroke and have to be carefully used in elderly patients who are aged > 75.</li><li>\u2022 Option B. Prasugrel</li><li>\u2022 Option C. Reteplase : Thrombolytic therapy, not indicated for NSTE-ACS.</li><li>\u2022 Option C. Reteplase</li><li>\u2022 Option D. Tirofiban : Gp IIb/IIIa inhibitor, typically used during PCI under special circumstances.</li><li>\u2022 Option D. Tirofiban</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 All patients with non\u2013ST-elevation acute coronary syndrome should be treated with aspirin and a P2Y12 inhibitor regardless of reperfusion strategy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "989857e4",
      "audio": ""
    },
    {
      "text": "A 69-year-old woman with a history of NSTEMI and AF underwent a successful PCI with a drug eluting stent. What is the most appropriate management of her antithrombotic therapy?",
      "options": [
        {
          "label": "A",
          "text": "Aspirin plus clopidogrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aspirin plus ticagrelor",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aspirin plus rivaroxaban plus ticagrelor",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rivaroxaban plus ticagrelor",
          "correct": true
        }
      ],
      "correct_answer": "D. Rivaroxaban plus ticagrelor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Aspirin plus clopidogrel: This is traditional dual antiplatelet therapy (DAPT) and does not address the need for anticoagulation in AF.</li><li>\u2022 Option A. Aspirin plus clopidogrel:</li><li>\u2022 Option B. Aspirin plus ticagrelor: Similar to option a, it lacks anticoagulation for AF.</li><li>\u2022 Option B. Aspirin plus ticagrelor:</li><li>\u2022 Option C. Aspirin plus rivaroxaban plus ticagrelor: Triple therapy is no longer recommended as it increases bleeding risk without significant additional benefit compared to dual therapy.</li><li>\u2022 Option C. Aspirin plus rivaroxaban plus ticagrelor:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Among patients with atrial fibrillation who have undergone percutaneous coronary intervention for acute coronary syndrome, double therapy with clopidogrel or ticagrelor plus a direct oral anticoagulant is recommended over triple therapy with an oral anticoagulant, aspirin, and P2Y12 inhibitor to reduce the risk for bleeding.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e8e24145",
      "audio": ""
    },
    {
      "text": "A 65-year-old woman is evaluated for a 6-week history of persistent fatigue and occasional exertional dyspnea. ECG is shown. Which of the following abnormalities best describes the findings on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Completed anterior myocardial infarction",
          "correct": false
        },
        {
          "label": "B",
          "text": "Completed inferior myocardial infarction",
          "correct": false
        },
        {
          "label": "C",
          "text": "Completed lateral myocardial infarction",
          "correct": true
        },
        {
          "label": "D",
          "text": "Completed posterior myocardial infarction",
          "correct": false
        }
      ],
      "correct_answer": "C. Completed lateral myocardial infarction",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-110228.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 This ECG shows a completed lateral myocardial infarction, with initial deep Q waves in leads I, aVL, and V6. There is also an inverted T wave in these leads.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a6b188c7",
      "audio": ""
    },
    {
      "text": "Which of the following statements is true when comparing ST-segment elevation myocardial infarctions (STEMI) versus non\u2013ST-segment elevation myocardial infarctions (NSTEMI)?",
      "options": [
        {
          "label": "A",
          "text": "There is a greater chance of finding an occlusive thrombus in a NSTEMI",
          "correct": false
        },
        {
          "label": "B",
          "text": "Patients with STEMI have more developed coronary collateral networks",
          "correct": false
        },
        {
          "label": "C",
          "text": "A person with a STEMI is more likely to have single-vessel disease than a person with a NSTEMI",
          "correct": true
        },
        {
          "label": "D",
          "text": "The thrombus in STEMI is more platelet-rich compared to that of NSTEMI",
          "correct": false
        }
      ],
      "correct_answer": "C. A person with a STEMI is more likely to have single-vessel disease than a person with a NSTEMI",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. There is a greater chance of finding an occlusive thrombus in a NSTEMI: This is incorrect. STEMI is caused by a complete occlusive thrombus, while NSTEMI may have partial or intermittent occlusion.</li><li>\u2022 Option A. There is a greater chance of finding an occlusive thrombus in a NSTEMI:</li><li>\u2022 Option B. Patients with STEMI have more developed coronary collateral networks: This is incorrect. Collateral circulation is more likely to develop in patients with chronic ischemia, such as those with chronic stable angina or NSTEMI.</li><li>\u2022 Option B. Patients with STEMI have more developed coronary collateral networks:</li><li>\u2022 Option D. The thrombus in STEMI is more platelet-rich compared to that of NSTEMI: Thrombus in STEMI is more fibrin rich and the thrombus in NSTEMI is more platelet rich.</li><li>\u2022 Option D. The thrombus in STEMI is more platelet-rich compared to that of NSTEMI:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understand that while both STEMI and NSTEMI involve myocardial infarction, STEMI is more often associated with single-vessel disease and complete coronary artery occlusion, while NSTEMI is often associated with multi-vessel disease or less severe occlusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b42d806e",
      "audio": ""
    },
    {
      "text": "A 51-year-old male presents with chest pain, 4 days after he was diagnosed with an ST elevation myocardial infarction (STEMI). It is severe, central chest pain with radiation to the trapezius and worse with deep inspiration. The pain woke him from sleep and has improved slightly after getting up out of bed. His Troponin levels were unchanged and ECG showed new saddle-shaped ST elevations in inferior and lateral leads. What is the likely cause?",
      "options": [
        {
          "label": "A",
          "text": "Recurrent MI",
          "correct": false
        },
        {
          "label": "B",
          "text": "Early Pericarditis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dressler's Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Severe GERD due to aspirin",
          "correct": false
        }
      ],
      "correct_answer": "B. Early Pericarditis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Recurrent MI: While possible, the unchanged troponin and the specific characteristics of the chest pain make it less likely.</li><li>\u2022 Option A. Recurrent MI:</li><li>\u2022 Option C. Dressler's Syndrome: This is a post-MI syndrome occurring weeks to months after the infarction, characterized by fever, pericarditis, pleuritis, and leukocytosis. It is too early for this diagnosis.</li><li>\u2022 Option C. Dressler's Syndrome:</li><li>\u2022 Option D. Severe GERD due to aspirin: GERD can cause chest pain, but the pain is typically burning and not pleuritic. Additionally, the ECG changes are not consistent with GERD.</li><li>\u2022 Option D. Severe GERD due to aspirin:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Early pericarditis is a common complication of STEMI that typically occurs in the first week after MI.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ff3dfb9d",
      "audio": ""
    },
    {
      "text": "A 52-year-old woman experiences shortness of breath after a recent MI that was treated with a drug-eluting stent. Her current medications are aspirin, ticagrelor, enalapril, metoprolol, and atorvastatin. Her physical examination, chest X-ray, and ECG are normal. Which of the following is the most likely cause of her dyspnea?",
      "options": [
        {
          "label": "A",
          "text": "Heart failure",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stent thrombosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ticagrelor side effect",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ventricular septal rupture",
          "correct": false
        }
      ],
      "correct_answer": "C. Ticagrelor side effect",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Heart failure : Unlikely given the normal physical exam and imaging findings.</li><li>\u2022 Option A. Heart failure</li><li>\u2022 Option B. Stent thrombosis : Usually presents with acute coronary syndrome symptoms and ECG changes.</li><li>\u2022 Option B. Stent thrombosis</li><li>\u2022 Option D. Ventricular septal rupture : Rare complication of MI, usually presents with shock and a new murmur.</li><li>\u2022 Option D. Ventricular septal rupture</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Dyspnea is a well-recognized and often self-limited side effect of ticagrelor therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c305f11",
      "audio": ""
    },
    {
      "text": "A 68-year-old woman with hypertension and type 2 diabetes mellitus presents to the ER with acute chest pain and diaphoresis. Her BP is 100/60 mm Hg and PR is. ECG is shown. Troponins are elevated. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac catheterization",
          "correct": true
        },
        {
          "label": "B",
          "text": "Echocardiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Permanent pacemaker implantation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Temporary pacing",
          "correct": false
        }
      ],
      "correct_answer": "A. Cardiac catheterization",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-111130.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Echocardiography : While useful for assessing LV function and complications of MI, it does not address the underlying cause of the arrhythmia (ischemia).</li><li>\u2022 Option B. Echocardiography</li><li>\u2022 Option C. Permanent pacemaker implantation : May be required if the conduction disturbance is persistent after revascularization.</li><li>\u2022 Option C. Permanent pacemaker implantation</li><li>\u2022 Option D. Temporary pacing : This could be considered if the patient becomes hemodynamically unstable or of there is a high grade AV block.</li><li>\u2022 Option D. Temporary pacing</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with acute inferior MI, Mobitz type I block and sinus bradycardia can be managed without pacing and the immediate treatment of choice would be reperfusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b35632b0",
      "audio": ""
    },
    {
      "text": "Mr. Thiru is admitted after an anterior MI. In the ICU, he has frequent premature ventricular contractions (PVCs) and lab results show S. K of 2.9 mEq/L and S. Mg of 1 mg/dL. Which of the following is NOT indicated in this setting?",
      "options": [
        {
          "label": "A",
          "text": "IV lidocaine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Magnesium repletion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metoprolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Potassium repletion",
          "correct": false
        }
      ],
      "correct_answer": "A. IV lidocaine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Magnesium repletion : Indicated to correct hypomagnesemia, which can trigger arrhythmias.</li><li>\u2022 Option B. Magnesium repletion</li><li>\u2022 Option C. Metoprolol : Beta-blocker, reduces myocardial oxygen demand and helps prevent arrhythmias.</li><li>\u2022 Option C. Metoprolol</li><li>\u2022 Option D. Potassium repletion : Indicated to correct hypokalemia, which can also trigger arrhythmias.</li><li>\u2022 Option D. Potassium repletion</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Beta-blockers and correction of electrolyte imbalances re essential in preventing arrhythmias and reducing mortality in acute MI.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "db2620e3",
      "audio": ""
    },
    {
      "text": "Which of the following medications should be avoided in patients with an acute ST-elevation myocardial infarction?",
      "options": [
        {
          "label": "A",
          "text": "Aspirin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Colchicine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glucocorticoids",
          "correct": true
        },
        {
          "label": "D",
          "text": "Metoprolol",
          "correct": false
        }
      ],
      "correct_answer": "C. Glucocorticoids",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Aspirin: Aspirin is an antiplatelet medication that is beneficial in STEMI. It helps prevent further clot formation and reduces the risk of complications.</li><li>\u2022 Option A. Aspirin:</li><li>\u2022 Option B. Colchicine: Colchicine is an anti-inflammatory medication that can be used in certain cases of pericarditis, but it is not contraindicated in STEMI.</li><li>\u2022 Option B. Colchicine:</li><li>\u2022 Option D. Metoprolol: Metoprolol is a beta-blocker that reduces heart rate and blood pressure, decreasing the workload on the heart. It is beneficial in STEMI unless there are specific contraindications.</li><li>\u2022 Option D. Metoprolol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 NSAIDs (except aspirin) and glucocorticoids are absolutely C/I in STEMI.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4466751",
      "audio": ""
    },
    {
      "text": "Approximately how long should patients with STEMI be advised to maintain bed rest after revascularization?",
      "options": [
        {
          "label": "A",
          "text": "6-12 hours",
          "correct": true
        },
        {
          "label": "B",
          "text": "24 hours",
          "correct": false
        },
        {
          "label": "C",
          "text": "48 hours",
          "correct": false
        },
        {
          "label": "D",
          "text": "72 hours",
          "correct": false
        }
      ],
      "correct_answer": "A. 6-12 hours",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. 24 hours, Option C. 48 hours and Option D. 72 hours: These durations are too long for bed rest after revascularization. Prolonged bed rest can lead to complications like deconditioning, deep vein thrombosis, and pneumonia. Early mobilization is encouraged to promote recovery and prevent these complications.</li><li>\u2022 Option B. 24 hours, Option C. 48 hours</li><li>\u2022 Option D. 72 hours:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Patients with STEMI should be advised to maintain bed rest for 6-12h after revascularization, followed by early mobilization to promote recovery and prevent complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c4486545",
      "audio": ""
    },
    {
      "text": "Mrs. Hinduja, a 64-year-old woman, had a drug-eluting (everolimus) stent placed one month ago for a recent MI. She is on dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. Her ophthalmologist wants to know if these can be stopped for a cataract surgery next week. What is the most appropriate advice?",
      "options": [
        {
          "label": "A",
          "text": "Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discontinue both aspirin and clopidogrel and proceed with cataract surgery.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Postpone the surgery for 6 months.",
          "correct": true
        }
      ],
      "correct_answer": "D. Postpone the surgery for 6 months.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery, Option B. Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery and Option C. Discontinue both aspirin and clopidogrel and proceed with cataract surgery : Stopping either or both antiplatelet medications prematurely increases the risk of stent thrombosis and is not recommended.</li><li>\u2022 Option A. Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery, Option B. Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery</li><li>\u2022 Option C. Discontinue both aspirin and clopidogrel and proceed with cataract surgery</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Stopping DES in the first 6 months is associated with increased risk of in-stent thrombosis and hence, elective surgeries must be postponed.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "66661b23",
      "audio": ""
    },
    {
      "text": "A 67-year-old woman with stable heart failure with reduced ejection fraction (HFrEF) is on maximum doses of lisinopril, among other medications. Which treatment is most appropriate to further reduce HF hospitalizations and mortality?",
      "options": [
        {
          "label": "A",
          "text": "Add digoxin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Add ivabradine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase carvedilol dosage",
          "correct": false
        },
        {
          "label": "D",
          "text": "Switch lisinopril to valsartan-sacubitril",
          "correct": true
        }
      ],
      "correct_answer": "D. Switch lisinopril to valsartan-sacubitril",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Digoxin: While it can reduce HF hospitalizations, it does not improve mortality.</li><li>\u2022 Option A. Digoxin:</li><li>\u2022 Option B. Ivabradine: Used for patients with HFrEF in sinus rhythm and a high heart rate despite beta-blocker therapy. Not applicable here.</li><li>\u2022 Option B. Ivabradine:</li><li>\u2022 Option C. Increasing carvedilol: Might not be tolerated well and has not shown the same mortality benefit as valsartan-sacubitril.</li><li>\u2022 Option C. Increasing carvedilol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Valsartan-sacubitril significantly reduces heart failure hospitalizations and mortality in patients with symptomatic heart failure with reduced ejection fraction and is recommended in preference to an ACE inhibitor or angiotensin receptor blocker.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "33f5107d",
      "audio": ""
    },
    {
      "text": "An 18-year-old athlete experiences cardiac arrest during a race and is successfully resuscitated. Resting ECG is shown. Echocardiogram shows normal LV function but RV dilation and dysfunction. What is the most appropriate management before discharge?",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Genetic testing",
          "correct": false
        },
        {
          "label": "C",
          "text": "Implantable cardioverter-defibrillator (ICD)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lisinopril",
          "correct": false
        }
      ],
      "correct_answer": "C. Implantable cardioverter-defibrillator (ICD)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-115610.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Amiodarone: Antiarrhythmic medication, but not as effective as ICD for preventing sudden death.</li><li>\u2022 Option A. Amiodarone:</li><li>\u2022 Option B. Genetic testing: Important for diagnosis and family screening, but not the immediate priority before discharge.</li><li>\u2022 Option B. Genetic testing:</li><li>\u2022 Option D. Lisinopril: ACE inhibitor for LV dysfunction, not indicated in this case with normal LV function.</li><li>\u2022 Option D. Lisinopril:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Patients with sustained ventricular arrhythmias (>30 seconds) or cardiac arrest without a reversible cause have a class 1 recommendation for secondary prevention with implantable cardioverter-defibrillator placement.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8a93e8b3",
      "audio": ""
    },
    {
      "text": "A 70-year-old man presents with ascites, pedal edema and elevated JVP. ECG showed low voltage complexes and echo showed increased LV wall thickness. He also has a history of carpal tunnel syndrome. What is the most appropriate test?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac MRI",
          "correct": true
        },
        {
          "label": "B",
          "text": "Exercise echocardiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Right and left heart catheterization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serum \u03b1-galactosidase level",
          "correct": false
        }
      ],
      "correct_answer": "A. Cardiac MRI",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Exercise echocardiography: Primarily used to diagnose coronary artery disease.</li><li>\u2022 Option B. Exercise echocardiography:</li><li>\u2022 Option C. Right and left heart catheterization: Invasive and not the first-line test for infiltrative cardiomyopathy.</li><li>\u2022 Option C. Right and left heart catheterization:</li><li>\u2022 Option D. Serum \u03b1-galactosidase level: Used to diagnose Fabry disease, which usually causes Hypertrophic Cardiomyopathy.</li><li>\u2022 Option D. Serum \u03b1-galactosidase level:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cardiac magnetic resonance imaging with gadolinium is highly sensitive and specific for cardiac amyloidosis, but it does not distinguish between AL (immunoglobulin light-chain) amyloidosis and transthyretin amyloidosis.</li><li>\u27a4 In patients with cardiac magnetic resonance imaging findings consistent with cardiac amyloidosis, an abnormal 99m-technetium pyrophosphate scan would confirm transthyretin amyloidosis without the need for a biopsy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94f9825f",
      "audio": ""
    },
    {
      "text": "A 43-year-old man with heart failure with mildly reduced ejection fraction (HFmrEF) and type 2 diabetes mellitus is asymptomatic and on appropriate medications. Which additional treatment is most appropriate?",
      "options": [
        {
          "label": "A",
          "text": "Digoxin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Empagliflozin (SGLT2 inhibitor)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ivabradine",
          "correct": false
        }
      ],
      "correct_answer": "B. Empagliflozin (SGLT2 inhibitor)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Digoxin: Reduces HF hospitalizations but not mortality, and this patient is asymptomatic.</li><li>\u2022 Option A. Digoxin:</li><li>\u2022 Option C. Furosemide: Loop diuretic, indicated for volume overload which is not present in this patient.</li><li>\u2022 Option C. Furosemide:</li><li>\u2022 Option D. Ivabradine: Used for HF with reduced ejection fraction (HFrEF) with high heart rates despite beta-blockers.</li><li>\u2022 Option D. Ivabradine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A sodium-glucose cotransporter 2 inhibitor is recommended to reduce risk for worsening heart failure and cardiovascular death in patients with type 2 diabetes mellitus and established heart failure with reduced ejection fraction</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7d9d2355",
      "audio": ""
    },
    {
      "text": "An 8-day postpartum woman presents with acute heart failure symptoms. Echocardiogram shows LV dilation and hypokinesis with an ejection fraction of 38%.RV is normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute pulmonary embolism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ascending aortic dissection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peripartum cardiomyopathy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Spontaneous coronary artery dissection",
          "correct": false
        }
      ],
      "correct_answer": "C. Peripartum cardiomyopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Acute pulmonary embolism : Less likely given normal right heart function on echocardiogram.</li><li>\u2022 Option A. Acute pulmonary embolism</li><li>\u2022 Option B. Ascending aortic dissection: Usually presents with acute chest pain, and echo would show aortic abnormalities.</li><li>\u2022 Option</li><li>\u2022 B. Ascending aortic dissection:</li><li>\u2022 Option D. Spontaneous coronary artery dissection: Typically presents with chest pain and ECG changes indicative of ischemia.</li><li>\u2022 Option</li><li>\u2022 D. Spontaneous coronary artery dissection:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Peripartum cardiomyopathy is left ventricular systolic dysfunction with onset toward the end of pregnancy or in the months after delivery in the absence of another identifiable cause; patients often present with features of heart failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d708d918",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with decompensated heart failure is hospitalized and treated with a maximal dose of IV furosemide. He has minimal urine output and persistent signs of volume overload. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Add intravenous milrinone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Add intravenous nitroglycerin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase furosemide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Start CVVH (Continuous venovenous hemofiltration)",
          "correct": true
        }
      ],
      "correct_answer": "D. Start CVVH (Continuous venovenous hemofiltration)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Add intravenous milrinone: Milrinone is an inotrope used to improve cardiac contractility. While it may help with cardiac output, it doesn't directly address the volume overload and can worsen renal function.</li><li>\u2022 Option A. Add intravenous milrinone:</li><li>\u2022 Option B. Add intravenous nitroglycerin: Nitroglycerin is a vasodilator that can reduce preload and afterload, but it's not the primary treatment for volume overload when diuretics fail.</li><li>\u2022 Option B. Add intravenous nitroglycerin:</li><li>\u2022 Option C. Increase furosemide: The patient is already on the maximal dose of furosemide, so further increases would not be effective and could lead to adverse effects.</li><li>\u2022 Option C. Increase furosemide:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with ADHF who are unresponsive to maximal diuretic therapy, CVVH is a crucial intervention to manage volume overload and prevent further complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c3cba583",
      "audio": ""
    },
    {
      "text": "A 56-year-old man with ischemic cardiomyopathy (EF 20%) is on maximally tolerated heart failure medications and experiencing significant functional decline. He wishes to pursue care that will restore functionality. What is the most appropriate long-term treatment?",
      "options": [
        {
          "label": "A",
          "text": "Digoxin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Heart transplantation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Left ventricular assist device (LVAD) placement",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tolvaptan",
          "correct": false
        }
      ],
      "correct_answer": "B. Heart transplantation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Digoxin: Although it can reduce hospitalizations, it does not improve survival or functional capacity.</li><li>\u2022 Option A. Digoxin:</li><li>\u2022 Option C. LVAD placement: LVADs are a bridge to transplantation or destination therapy for those who are not transplant candidates. This patient may be eligible for transplant.</li><li>\u2022 Option C. LVAD placement:</li><li>\u2022 Option D. Tolvaptan: Used for hyponatremia, but not a primary treatment for advanced heart failure.</li><li>\u2022 Option D. Tolvaptan:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Patients with persistent severe heart failure symptoms despite maximal medical therapy are candidates for advanced treatment; acceptable candidates for cardiac transplantation are generally younger than 65 to 70 years with no medical contraindications and have good social support and adherence.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4d710275",
      "audio": ""
    },
    {
      "text": "A 47-year-old man with a history of HFrEF and AF, presents for follow-up with stable NYHA class III symptoms. He is currently on losartan, carvedilol, empagliflozin, furosemide, and apixaban. He has a history of ACE inhibitor-induced angioedema and spironolactone-induced gynecomastia. Which medication is the most appropriate addition to his current regimen?",
      "options": [
        {
          "label": "A",
          "text": "Add eplerenone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Add ivabradine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Switch carvedilol to metoprolol succinate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Switch losartan to valsartan-sacubitril",
          "correct": false
        }
      ],
      "correct_answer": "A. Add eplerenone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Ivabradine: Not indicated in patients with atrial fibrillation.</li><li>\u2022 Option</li><li>\u2022 B. Ivabradine:</li><li>\u2022 Option C. Switch carvedilol to metoprolol succinate: Not necessary, as there is no evidence of benefit in switching between beta-blockers in this scenario.</li><li>\u2022 Option</li><li>\u2022 C. Switch carvedilol to metoprolol succinate:</li><li>\u2022 benefit in switching between beta-blockers in this scenario.</li><li>\u2022 Option D. Switch losartan to valsartan-sacubitril: Contraindicated due to the history of ACE inhibitor-induced angioedema.</li><li>\u2022 Option</li><li>\u2022 D. Switch losartan to valsartan-sacubitril:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Aldosterone antagonist therapy (spironolactone, eplerenone) is indicated in all patients with symptomatic heart failure with reduced ejection fraction and normal kidney function to improve survival.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7e30b710",
      "audio": ""
    },
    {
      "text": "A 42-year-old man with hypertrophic cardiomyopathy (HCM) diagnosed at age 38 presents with exertional dyspnea. He is on metoprolol and disopyramide. Echocardiogram shows asymmetric septal hypertrophy, systolic anterior motion of the mitral valve (SAM), and a resting LVOT gradient of 64 mmHg. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Addition of valsartan-sacubitril",
          "correct": false
        },
        {
          "label": "B",
          "text": "Implantable cardioverter-defibrillator (ICD) therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Replacement of metoprolol with carvedilol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Septal reduction therapy (SRT)",
          "correct": true
        }
      ],
      "correct_answer": "D. Septal reduction therapy (SRT)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Valsartan-sacubitril: This medication is contraindicated in HCM due to the risk of worsening LVOT obstruction.</li><li>\u2022 Option</li><li>\u2022 A. Valsartan-sacubitril:</li><li>\u2022 Option B. ICD therapy: Indicated for primary prevention of sudden cardiac death in high-risk HCM patients but not the primary treatment for symptoms.</li><li>\u2022 Option</li><li>\u2022 B. ICD therapy:</li><li>\u2022 Option C. Replacement of metoprolol with carvedilol: Unlikely to be beneficial as both are beta-blockers.</li><li>\u2022 Option</li><li>\u2022 C. Replacement of metoprolol with carvedilol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Septal reduction therapy is indicated for symptomatic HCM patients with a significant LVOT gradient despite optimal medical therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d83869e",
      "audio": ""
    },
    {
      "text": "A 76-year-old woman presents with acute substernal chest discomfort and dyspnea after seeing her dog being attacked and killed by another dog. Her echocardiogram shows apical and mid-ventricular hypokinesis with preserved basal function, and coronary angiography is normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Ascending aortic dissection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Coronary artery dissection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coronary artery embolism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Takotsubo cardiomyopathy",
          "correct": true
        }
      ],
      "correct_answer": "D. Takotsubo cardiomyopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Ascending aortic dissection: This would typically present with severe tearing chest pain radiating to the back.</li><li>\u2022 Option</li><li>\u2022 A.  Ascending aortic dissection:</li><li>\u2022 Option B. Coronary artery dissection: This would show abnormalities on angiography.</li><li>\u2022 Option</li><li>\u2022 B. Coronary artery dissection:</li><li>\u2022 Option C. Coronary artery embolism: This would also cause regional wall motion abnormalities on echocardiogram.</li><li>\u2022 Option</li><li>\u2022 C. Coronary artery embolism:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Takotsubo cardiomyopathy is a syndrome characterized by transient regional systolic ventricular dysfunction mimicking myocardial infarction in the absence of angiographic evidence of obstructive coronary artery disease.</li><li>\u27a4 Treatment of takotsubo cardiomyopathy is similar to that for heart failure of other causes; most patients recover cardiac function over several months.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b8b9824f",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with restrictive cardiomyopathy and atrial fibrillation presents with refractory heart failure symptoms despite optimal medical therapy. Echo shows an EF of 50%, severe biatrial enlargement and pulmonary hypertension. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac resynchronization therapy (CRT)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cardiac transplantation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Implantable cardioverter-defibrillator (ICD)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary vein isolation",
          "correct": false
        }
      ],
      "correct_answer": "B. Cardiac transplantation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. CRT: Not indicated in patients with preserved EF.</li><li>\u2022 Option</li><li>\u2022 A. CRT:</li><li>\u2022 Option C. ICD: Not indicated for primary prevention in a patient with preserved EF.</li><li>\u2022 Option</li><li>\u2022 C. ICD:</li><li>\u2022 Option D. Pulmonary vein isolation: May not be effective in patients with severe atrial enlargement and underlying restrictive cardiomyopathy.</li><li>\u2022 Option</li><li>\u2022 D. Pulmonary vein isolation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Heart transplantation is an effective therapy for select patients with end-stage restrictive cardiomyopathy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1940c4d4",
      "audio": ""
    },
    {
      "text": "A 27-year-old woman, 6 days postpartum, presents with acute heart failure symptoms (orthopnea, paroxysmal nocturnal dyspnea, elevated JVP, S3, crackles, edema). Echocardiogram shows an ejection fraction (EF) of 20% and diffuse hypokinesis. She is currently on furosemide and bilevel positive airway pressure (BiPAP). What is the most appropriate additional treatment?",
      "options": [
        {
          "label": "A",
          "text": "Bisoprolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diltiazem",
          "correct": false
        },
        {
          "label": "C",
          "text": "Enalapril",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ivabradine",
          "correct": false
        }
      ],
      "correct_answer": "C. Enalapril",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bisoprolol (beta-blocker): While beneficial in HFrEF, it should be initiated cautiously after volume status is optimized in acute decompensated heart failure.</li><li>\u2022 Option</li><li>\u2022 A. Bisoprolol (beta-blocker):</li><li>\u2022 Option B. Diltiazem (non-dihydropyridine calcium channel blocker): Contraindicated in HFrEF due to negative inotropic effects.</li><li>\u2022 Option</li><li>\u2022 B. Diltiazem (non-dihydropyridine calcium channel blocker):</li><li>\u2022 Option D. Ivabradine: Used in HFrEF patients with sinus rhythm and elevated heart rate despite optimal beta-blocker therapy.</li><li>\u2022 Option</li><li>\u2022 D. Ivabradine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ACE inhibitors reduce morbidity and mortality in patients with heart failure with reduced ejection fraction and should be used in both symptomatic and asymptomatic patients.</li><li>\u27a4 Metoprolol, carvedilol, and bisoprolol reduce mortality in patients with heart failure with reduced ejection fraction, but treatment should be delayed in patients with volume overload until the patient is closer to being euvolemic.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aaeebeca",
      "audio": ""
    },
    {
      "text": "An 18-year-old man with no prior medical history undergoes a pre-participation sports examination. ECG shows sinus bradycardia and voltage criteria for left ventricular (LV) hypertrophy. Echocardiogram shows mild LV dilation and symmetric LV hypertrophy with a normal LV ejection fraction and diastolic function. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Athlete's heart",
          "correct": true
        },
        {
          "label": "B",
          "text": "Fabry disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypertensive heart disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nonobstructive hypertrophic cardiomyopathy (HCM)",
          "correct": false
        }
      ],
      "correct_answer": "A. Athlete's heart",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Fabry disease: A lysosomal storage disorder that can cause LV hypertrophy but is also associated with other systemic manifestations like angiokeratomas and renal dysfunction.</li><li>\u2022 Option B. Fabry disease:</li><li>\u2022 Option C. Hypertensive heart disease: Usually occurs in older individuals with a history of hypertension.</li><li>\u2022 Option</li><li>\u2022 C. Hypertensive heart disease:</li><li>\u2022 Option D. Nonobstructive HCM: A genetic disorder that causes asymmetric LV hypertrophy and often has impaired diastolic function.</li><li>\u2022 Option</li><li>\u2022 D. Nonobstructive HCM:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Increased left ventricular (LV) wall thickness and LV cavity dilatation may be normal findings in highly trained athletes; symmetric wall thickness of 13 mm or less and normal diastolic filling favor the diagnosis of athlete heart over the diagnosis of HCM.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b39bde0",
      "audio": ""
    },
    {
      "text": "A 63-year-old man who is a known case of HFrEF presents with persistent NYHA III symptoms despite optimal medical therapy. ECG shows LBBB and echo shows an EF of 25%. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac resynchronization therapy-defibrillator (CRT-D)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Implantable cardioverter-defibrillator (ICD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Implantable pulmonary artery pressure sensor",
          "correct": false
        },
        {
          "label": "D",
          "text": "Wearable cardioverter-defibrillator",
          "correct": false
        }
      ],
      "correct_answer": "A. Cardiac resynchronization therapy-defibrillator (CRT-D)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. ICD: May be indicated for primary prevention of sudden cardiac death but doesn't address the LBBB and dyssynchrony.</li><li>\u2022 Option</li><li>\u2022 B. ICD:</li><li>\u2022 Option C. Implantable pulmonary artery pressure sensor: Used for monitoring, not for treating heart failure.</li><li>\u2022 Option</li><li>\u2022 C. Implantable pulmonary artery pressure sensor:</li><li>\u2022 Option D. Wearable cardioverter-defibrillator: Temporary measure, not appropriate for long-term management of heart failure.</li><li>\u2022 Option</li><li>\u2022 D. Wearable cardioverter-defibrillator:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cardiac resynchronization therapy is indicated in patients with New York Heart Association functional class II to IV symptoms despite guideline-directed medical therapy who have an ejection fraction of 35% or less, sinus rhythm, and left bundle branch block with a QRS duration of 150 ms or longer.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1786a941",
      "audio": ""
    },
    {
      "text": "A 78-year-old woman with hypertension and paroxysmal AF presents with a 6-month history of exertional dyspnea. She has normal vital signs, clear lungs, and a normal JVP. Echocardiography shows an ejection fraction of 55%, increased left ventricular wall thickness, and an enlarged left atrium. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Heart failure with preserved ejection fraction (HFpEF)",
          "correct": true
        },
        {
          "label": "B",
          "text": "High-output heart failure",
          "correct": false
        },
        {
          "label": "C",
          "text": "HOCM",
          "correct": false
        },
        {
          "label": "D",
          "text": "HFrEF",
          "correct": false
        }
      ],
      "correct_answer": "A. Heart failure with preserved ejection fraction (HFpEF)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. High-output heart failure: This is associated with an elevated cardiac index, which is not present in this case.</li><li>\u2022 Option</li><li>\u2022 B. High-output heart failure:</li><li>\u2022 Option C. HOCM: This would show LV outflow tract obstruction, which is absent in this patient.</li><li>\u2022 Option</li><li>\u2022 C. HOCM:</li><li>\u2022 Option D. HFrEF: Unlikley given the normal EF in this patient.</li><li>\u2022 Option</li><li>\u2022 D. HFrEF:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HFpEF should be suspected in patients who meet the following three criteria: symptoms of heart failure, left ventricular ejection fraction of 50% or greater, and no other apparent cause of HF symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "432d75fe",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman with hypertrophic cardiomyopathy (HCM) experiences an episode of syncope and was admitted. 2D Echo revealed a maximum LV wall thickness of 30 mm and a dynamic LVOT obstruction. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Disopyramide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Implantable cardioverter-defibrillator (ICD)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Septal reduction therapy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Verapamil",
          "correct": false
        }
      ],
      "correct_answer": "B. Implantable cardioverter-defibrillator (ICD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Disopyramide: Primarily used for treating HF symptoms in HCM (in case if \u03b2B or CCB therapy is ineffective)</li><li>\u2022 Option</li><li>\u2022 A. Disopyramide:</li><li>\u2022 Option C.  Septal reduction therapy: Indicated for symptomatic patients with significant LVOT obstruction, but not for primary prevention of SCD.</li><li>\u2022 Option</li><li>\u2022 C.  Septal reduction therapy:</li><li>\u2022 Option D. Verapamil: Used for symptom relief in HCM, but not for SCD prevention.</li><li>\u2022 Option</li><li>\u2022 D. Verapamil:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Consider ICD therapy for primary prevention of SCD in patients with HCM and high-risk features.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c53af3cf",
      "audio": ""
    },
    {
      "text": "A 74-year-old man presents with progressive fatigue, dyspnea and edema. He has a history of ischemic cardiomyopathy with an EF of 10% and had 4 hospitalizations in the last 6 months. He is currently on sacubitril-valsartan, carvedilol, eplerenone, furosemide and empagliflozin. Labs reveal a S. creatinine of 1.7 mg/dL and S. Na of 128 mEq/L. What is the most reasonable next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Heart transplant",
          "correct": false
        },
        {
          "label": "B",
          "text": "ECMO",
          "correct": false
        },
        {
          "label": "C",
          "text": "Left ventricular assist device (LVAD) placement",
          "correct": true
        },
        {
          "label": "D",
          "text": "Add H-ISDN",
          "correct": false
        }
      ],
      "correct_answer": "C. Left ventricular assist device (LVAD) placement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Heart transplant: This patient is not a candidate for heart transplant based on his age and recent colon cancer. Most centers have an age cutoff of 65 years (but variable). With the exception of skin cancer, most programs require that a patient be cancer-free for at least 5 years before being considered for heart transplant.</li><li>\u2022 Option</li><li>\u2022 A. Heart transplant:</li><li>\u2022 Option B. Ecmo: Ecmo is a short-term life support option and is not suitable for long-term management of heart failure. it is typically reserved for refractory acute heart failure.</li><li>\u2022 Option</li><li>\u2022 B. Ecmo:</li><li>\u2022 Option C.  Add H-ISDN: Adding another medication would not be expected to provide significant benefit in this case of severe heart failure with maximized GDMT. Typically, H-ISDN is used for patients who are not able to tolerate ARNi/ACEi and ARB.</li><li>\u2022 Option</li><li>\u2022 C.  Add H-ISDN:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Left ventricular assist devices, either as a bridge to heart transplant or as primary therapy, are reasonable in patients with advanced heart failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "43db3ad0",
      "audio": ""
    },
    {
      "text": "A 65-year-old woman with paroxysmal AF and HFrEF (EF 45%) has recurrent hospitalizations due to acute heart failure. She is currently on apixaban, metoprolol, furosemide, and telmisartan. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Atrioventricular (AV) node ablation with permanent pacemaker implantation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Implantable cardioverter-defibrillator (ICD) placement",
          "correct": false
        },
        {
          "label": "C",
          "text": "Left atrial appendage occlusion (LAAO)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rhythm control",
          "correct": true
        }
      ],
      "correct_answer": "D. Rhythm control",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. AV node ablation: Considered only if rate and rhythm control fails to control tachycardia.</li><li>\u2022 Option A. AV node ablation:</li><li>\u2022 Option B. ICD: Indicated for primary prevention of sudden cardiac death in certain patients, but not the primary treatment for this patient.</li><li>\u2022 Option B. ICD:</li><li>\u2022 Option C. LAAO: Used for stroke prevention in patients who have C/I for anticoagulation.</li><li>\u2022 Option C. LAAO:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Aggressive efforts to achieve rhythm control in patients with atrial fibrillation and concomitant heart failure decrease morbidity and mortality.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f94f26e8",
      "audio": ""
    },
    {
      "text": "A 57-year-old woman with ischemic cardiomyopathy (EF 38%) and type 2 diabetes mellitus has well-controlled blood pressure and glycemic control. She is on aspirin, atorvastatin, valsartan-sacubitril, metoprolol succinate, and metformin. Her BNP. What is the most appropriate additional treatment?",
      "options": [
        {
          "label": "A",
          "text": "Liraglutide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glimepiride",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dapagliflozin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Saxagliptin",
          "correct": false
        }
      ],
      "correct_answer": "C. Dapagliflozin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Glimepiride (sulfonylurea): No proven cardiovascular benefit.</li><li>\u2022 Option B. Glimepiride (sulfonylurea):</li><li>\u2022 Option C. Liraglutide: Shown to reduce CV events in T2DM but not specifically in HFrEF.</li><li>\u2022 Option C. Liraglutide:</li><li>\u2022 Option D. Saxagliptin: Not recommended in HFrEF due to the potential for increased hospitalizations.</li><li>\u2022 Option D. Saxagliptin:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Consider adding SGLT2 inhibitors in patients with HFrEF, even if their diabetes is well-controlled, to reduce CV morbidity and mortality.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbddb911",
      "audio": ""
    },
    {
      "text": "A 69-year-old woman is evaluated in the emergency department for a 1-week history of progressive exertional dyspnea and orthopnea. Vital signs are normal. Focused point-of-care cardiac ultrasonography is performed and done and as shown below. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Aortic stenosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cardiac tamponade",
          "correct": false
        },
        {
          "label": "C",
          "text": "Heart failure with reduced ejection fraction",
          "correct": true
        },
        {
          "label": "D",
          "text": "Large pericardial effusion",
          "correct": false
        }
      ],
      "correct_answer": "C. Heart failure with reduced ejection fraction",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/supawork-e53ff9bb04dd417abdf7b818ed4326bc.gif"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Heart failure with reduced ejection fraction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Aortic stenosis : Aortic stenosis typically presents with symptoms such as chest pain, syncope, and heart failure. However, the ultrasound findings do not suggest aortic valve pathology or significant left ventricular outflow obstruction.</li><li>\u2022 Option A. Aortic stenosis</li><li>\u2022 Option B. Cardiac tamponade : Cardiac tamponade would present with findings such as hypotension, jugular venous distension, and pulsus paradoxus. The ultrasound in tamponade typically shows a large pericardial effusion with diastolic collapse of the right atrium or right ventricle. These findings are not present in this case.</li><li>\u2022 Option B. Cardiac tamponade</li><li>\u2022 Option D. Large pericardial effusion : A large pericardial effusion would show a significant fluid accumulation around the heart on ultrasound, often leading to tamponade physiology. This is not observed in the provided ultrasound image.</li><li>\u2022 Option D. Large pericardial effusion</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Recognize the clinical presentation of heart failure with reduced ejection fraction (HFrEF) and correlate it with echocardiographic findings, emphasizing the importance of identifying left ventricular systolic dysfunction in patients presenting with symptoms of heart failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0aa8144a",
      "audio": ""
    },
    {
      "text": "A 70-year-old man is evaluated in the emergency department for acute worsening of dyspnea. Chest radiograph is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac tamponade",
          "correct": false
        },
        {
          "label": "B",
          "text": "Eosinophilic pneumonia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lymphangioleiomyomatosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary edema",
          "correct": true
        }
      ],
      "correct_answer": "D. Pulmonary edema",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-115748.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Cardiac tamponade : While cardiomegaly can be seen in cardiac tamponade, which is a condition where fluid accumulates in the sac surrounding the heart, leading to compression of the heart, diffuse alveolar infiltrates are not a feature of cardiac tamponade. Therefore, this diagnosis is unlikely based on the radiographic findings.</li><li>\u2022 Option A. Cardiac tamponade</li><li>\u2022 Option B. Eosinophilic pneumonia : Eosinophilic pneumonia is characterized by the presence of eosinophils (a type of white blood cell) in the lung tissue, which typically presents with bilateral infiltrates on a chest radiograph. However, this condition does not usually present with cardiomegaly or pleural effusion, making this option less likely given the findings on the radiograph.</li><li>\u2022 Option B. Eosinophilic pneumonia</li><li>\u2022 Option C. Lymphangioleiomyomatosis: Lymphangioleiomyomatosis is a rare lung disease that affects the lungs and lymphatic system, leading to cystic lung disease. The chest radiograph for this condition would typically show diffuse thin-walled cysts rather than cardiomegaly, alveolar infiltrates, or pleural effusion. Thus, this diagnosis is inconsistent with the radiographic findings in this patient.</li><li>\u2022 Option</li><li>\u2022 C. Lymphangioleiomyomatosis:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Pulmonary edema is characterized by cardiomegaly and bilateral perihilar alveolar infiltrates on a chest radiograph, often associated with pleural effusion and fluid in the minor fissure, especially in the context of heart failure. This is a key diagnostic feature that must be remembered.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2de6318",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with a past medical history of coronary artery disease develops a myocardial infarction. He got treated in CCU and before he is discharged, he undergoes echocardiography, which reveals a left ventricular ejection fraction of 35% to 40%. He is asymptomatic. Repeat Echo after 3 months shows the same findings. What is this patient\u2019s heart failure stage?",
      "options": [
        {
          "label": "A",
          "text": "Stage A",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stage B",
          "correct": true
        },
        {
          "label": "C",
          "text": "Stage C",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stage D",
          "correct": false
        }
      ],
      "correct_answer": "B. Stage B",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Stage A: Patients in Stage A have risk factors for HF but no structural heart disease or symptoms.</li><li>\u2022 Option A. Stage A:</li><li>\u2022 Option C. Stage C: Patients in Stage C have structural heart disease and current or prior symptoms of HF.</li><li>\u2022 Option C. Stage C:</li><li>\u2022 Option D. Stage D: Patients in Stage D have refractory HF requiring specialized interventions.</li><li>\u2022 Option D. Stage D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ACC/AHA staging system for heart failure, categorizes patients based on the presence or absence of structural heart disease and symptoms of heart failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3336f066",
      "audio": ""
    },
    {
      "text": "A 64-year-old woman with a history of recurrent heart failure hospitalizations presents with ascites and edema. Her JVP was elevated and there was no change with inspiration. On examination, she has an audible low-pitched late diastolic sound with a pansystolic murmur in the left sternal border. Echo shows diastolic dysfunction with mildly increased LV wall thickness. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Constrictive pericarditis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fabry disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dilated Cardiomyopathy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Restrictive cardiomyopathy",
          "correct": true
        }
      ],
      "correct_answer": "D. Restrictive cardiomyopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Constrictive pericarditis: While this can also cause elevated JVP and diastolic dysfunction, it usually does not present with a pansystolic murmur or S3 gallop. Pericardial knock is more characteristic.</li><li>\u2022 Option A. Constrictive pericarditis:</li><li>\u2022 Option B. Fabry disease: This is a rare genetic disorder that can cause RCM, but it is less likely than other causes in this patient without a specific family history or other suggestive features.</li><li>\u2022 Option B. Fabry disease:</li><li>\u2022 Option C. Dilated cardiomyopathy: This presents with systolic dysfunction (reduced ejection fraction) and a dilated left ventricle, which are not seen in this case.</li><li>\u2022 Option C. Dilated cardiomyopathy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Restrictive cardiomyopathy presents with features of right heart failure, Kussmaul's sign, S3/S4 gallop, diastolic dysfunction, and associated findings like TR.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ba43831",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman with a history HF and HCM presents with NYHA class III dyspnea. She is currently on metoprolol and disopyramide. Echocardiogram shows an EF of 78% and LVOT gradient of 64 mmHg at rest. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Addition of valsartan-sacubitril",
          "correct": false
        },
        {
          "label": "B",
          "text": "Implantable cardioverter-defibrillator (ICD) therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Replacement of metoprolol with carvedilol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Septal reduction therapy (SRT)",
          "correct": true
        }
      ],
      "correct_answer": "D. Septal reduction therapy (SRT)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Valsartan-sacubitril: Contraindicated in HCM as it can worsen LVOT obstruction.</li><li>\u2022 Option</li><li>\u2022 A. Valsartan-sacubitril:</li><li>\u2022 Option B.  ICD: Indicated for primary prevention of sudden cardiac death in high-risk HCM patients, but not for symptomatic relief of LVOT obstruction.</li><li>\u2022 Option</li><li>\u2022 B.  ICD:</li><li>\u2022 Option C. Replacing metoprolol with carvedilol: Unlikely to be beneficial, as both are beta-blockers.</li><li>\u2022 Option</li><li>\u2022 C. Replacing metoprolol with carvedilol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Septal reduction therapy is the treatment of choice for symptomatic patients with HCM and a high LVOT gradient despite optimal medical therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "44ee6ab5",
      "audio": ""
    },
    {
      "text": "A 52-year-old man presents with dyspnea on exertion. His resting ECG is normal. 2D echo revealed diastolic dysfunction, mild concentric LVH, and an LV EF of 65%. His BNP levels were elevated. Which of the following will maximally increase survival in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Sacubitril-Valsartan",
          "correct": false
        },
        {
          "label": "B",
          "text": "Empagliflozin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Spironolactone",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. None of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Sacubitril-Valsartan: This is an angiotensin receptor-neprilysin inhibitor (ARNI) indicated for HFrEF, not HFpEF.</li><li>\u2022 Option</li><li>\u2022 A. Sacubitril-Valsartan:</li><li>\u2022 Option B. Empagliflozin: This is an SGLT2 inhibitor shown to benefit patients with HFrEF and may reduce hospitalizations in HFpEF, but not proven to improve survival.</li><li>\u2022 Option</li><li>\u2022 B. Empagliflozin:</li><li>\u2022 Option C. Spironolactone: While this mineralocorticoid receptor antagonist may improve symptoms and reduce hospitalizations in HFpEF, it has not been shown to reduce mortality.</li><li>\u2022 Option</li><li>\u2022 C. Spironolactone:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 There are no medications currently proven to significantly improve survival in HFpEF. Management primarily focuses on symptom management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2a2831f0",
      "audio": ""
    },
    {
      "text": "Circumferential subendocardial late-gadolinium enhancement (LGE) is seen in?",
      "options": [
        {
          "label": "A",
          "text": "Amyloidosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sarcoidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Myocarditis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ischemic heart disease (IHD)",
          "correct": false
        }
      ],
      "correct_answer": "A. Amyloidosis",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/untitled-2.jpg"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Sarcoidosis: Sarcoidosis typically shows a patchy or focal pattern of LGE, often in the mid-myocardial or subepicardial layers.</li><li>\u2022 Option B. Sarcoidosis:</li><li>\u2022 Option C. Myocarditis: Myocarditis can have various patterns of LGE, including patchy, focal, or epicardial, depending on the extent and distribution of inflammation.</li><li>\u2022 Option C. Myocarditis:</li><li>\u2022 Option D. Ischemic heart disease (IHD): IHD typically shows subendocardial or transmural LGE in a coronary artery distribution, corresponding to areas of infarction or ischemia.</li><li>\u2022 Option D. Ischemic heart disease (IHD):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Circumferential subendocardial late-gadolinium enhancement (LGE) on cardiac MRI is a hallmark feature of cardiac amyloidosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2b99f40",
      "audio": ""
    },
    {
      "text": "Proportion of sudden cardiac death (SCD) in heart failure is maximum among which of the following NYHA classes?",
      "options": [
        {
          "label": "A",
          "text": "Class I",
          "correct": false
        },
        {
          "label": "B",
          "text": "Class II",
          "correct": true
        },
        {
          "label": "C",
          "text": "Class III",
          "correct": false
        },
        {
          "label": "D",
          "text": "Class IV",
          "correct": false
        }
      ],
      "correct_answer": "B. Class II",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Proportion of deaths due to SCD is highest in NYHA Class II.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d322b3f5",
      "audio": ""
    },
    {
      "text": "Ms. Kalavathy, a 35-year-old Anglo-Indian from Ireland, experienced cardiac arrest due to monomorphic VT with a LBBB morphology. Coronary angiogram and echocardiogram were normal. Echo is shown. Which protein mutation is most likely responsible for her presentation?",
      "options": [
        {
          "label": "A",
          "text": "Potassium channels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Desmosomal proteins",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sodium channels",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sarcomere proteins",
          "correct": false
        }
      ],
      "correct_answer": "B. Desmosomal proteins",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-124018.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Potassium channels: Mutations in these channels cause long QT syndrome, characterized by a prolonged QT interval on ECG and syncope.</li><li>\u2022 Option</li><li>\u2022 A. Potassium channels:</li><li>\u2022 Option C. Sodium channel: Mutations in these channels cause Brugada syndrome, characterized by a specific ECG pattern and increased risk of sudden cardiac death.</li><li>\u2022 Option</li><li>\u2022 C. Sodium channel:</li><li>\u2022 Option D . Sarcomere proteins: Mutations in these proteins cause hypertrophic cardiomyopathy, which would show LV hypertrophy on echocardiogram.</li><li>\u2022 Option D</li><li>\u2022 . Sarcomere proteins:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ARVC is a rare genetic disorder most commonly due to mutations in genes encoding cardiac desmosomal proteins. Approximately 50% have a familial transmission with autosomal dominant inheritance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d16d627b",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with a history of MI and HF is comfortable at rest. However, when walking to his car, he develops dyspnea, fatigue, and sometimes palpitations. He must rest for several minutes before these symptoms resolve. Which of the following is his NYHA classification?",
      "options": [
        {
          "label": "A",
          "text": "Class I",
          "correct": false
        },
        {
          "label": "B",
          "text": "Class II",
          "correct": false
        },
        {
          "label": "C",
          "text": "Class III",
          "correct": true
        },
        {
          "label": "D",
          "text": "Class IV",
          "correct": false
        }
      ],
      "correct_answer": "C. Class III",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath), or angina.</li><li>\u2022 Option A. Class I:</li><li>\u2022 Option B. Class II: Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.</li><li>\u2022 Option B. Class II:</li><li>\u2022 Option D. Class IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.</li><li>\u2022 Option D. Class IV:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 In the NYHA classification, Class III heart failure is defined by marked limitation of physical activity where patients are comfortable at rest, but less than ordinary activity (e.g., walking short distances) causes symptoms such as dyspnea, fatigue, and palpitations.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "161f3194",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a symptom of heart failure?",
      "options": [
        {
          "label": "A",
          "text": "Confusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Early hunger",
          "correct": true
        },
        {
          "label": "C",
          "text": "Nocturia without polyuria",
          "correct": false
        },
        {
          "label": "D",
          "text": "Right upper quadrant pain",
          "correct": false
        }
      ],
      "correct_answer": "B. Early hunger",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Early hunger</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Confusion: This can occur in HF, particularly in older adults or those with severe HF. It is often due to decreased cerebral perfusion caused by reduced cardiac output.</li><li>\u2022 Option A. Confusion:</li><li>\u2022 Option C. Nocturia without polyuria: This is a common symptom of HF, especially in the early stages. It is caused by redistribution of fluid from the legs to the central circulation when lying down.</li><li>\u2022 Option C. Nocturia without polyuria:</li><li>\u2022 Option D. Right upper quadrant pain: This can be caused by liver congestion due to right heart failure.</li><li>\u2022 Option D. Right upper quadrant pain:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Recognize the various symptoms of heart failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2f43eaf4",
      "audio": ""
    },
    {
      "text": "All of the following are a risk factor for development of peripartum cardiomyopathy EXCEPT:",
      "options": [
        {
          "label": "A",
          "text": "Advanced maternal age",
          "correct": false
        },
        {
          "label": "B",
          "text": "Malnutrition",
          "correct": false
        },
        {
          "label": "C",
          "text": "Primiparous",
          "correct": true
        },
        {
          "label": "D",
          "text": "Twin pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "C. Primiparous",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Advanced maternal age: Advanced maternal age is a recognized risk factor for peripartum cardiomyopathy due to the increased cardiovascular strain and the higher likelihood of pre-existing heart conditions in older pregnant women.</li><li>\u2022 Option</li><li>\u2022 A. Advanced maternal age:</li><li>\u2022 Option B. Malnutrition: Malnutrition is another risk factor because inadequate nutrition can impair the heart muscle's ability to function properly, thereby increasing the risk of developing cardiomyopathy.</li><li>\u2022 Option</li><li>\u2022 B. Malnutrition:</li><li>\u2022 Option D. Twin pregnancy: A twin pregnancy significantly increases the workload on the heart, making it a well-documented risk factor for peripartum cardiomyopathy.</li><li>\u2022 Option</li><li>\u2022 D. Twin pregnancy:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Primiparous status (first pregnancy) is not a risk factor for peripartum cardiomyopathy, whereas advanced maternal age, malnutrition, and twin pregnancy are significant risk factors for the development of this condition.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a50236fb",
      "audio": ""
    },
    {
      "text": "You admit a 19-year-old with acute HF and LV dysfunction. After assessment, you suspect acute viral myocarditis, which is confirmed on endomyocardial biopsy. Which of the following therapies is recommended for treatment for acute viral myocarditis?",
      "options": [
        {
          "label": "A",
          "text": "Ibuprofen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ramipril",
          "correct": true
        },
        {
          "label": "C",
          "text": "Oseltamivir",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prednisone",
          "correct": false
        }
      ],
      "correct_answer": "B. Ramipril",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Ramipril</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Ibuprofen: Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID). Although it is commonly used to reduce inflammation and pain, its use is generally avoided in viral myocarditis. This is because NSAIDs can potentially increase the risk of adverse outcomes by inhibiting prostaglandin synthesis, which is essential for maintaining renal function and controlling inflammatory responses. Furthermore, NSAIDs might increase viral replication, leading to worsening of the condition.</li><li>\u2022 Option A. Ibuprofen:</li><li>\u2022 Option C. Oseltamivir: Oseltamivir is an antiviral medication primarily used to treat influenza. It is not effective for treating viral myocarditis because it specifically targets the influenza virus and has not been studied for cardiac involvement. Therefore, it is not recommended for the treatment of viral myocarditis.</li><li>\u2022 Option C. Oseltamivir:</li><li>\u2022 Option D. Prednisone: Prednisone is a corticosteroid with potent anti-inflammatory effects. However, the use of immunosuppressive therapies, including corticosteroids like prednisone, is generally avoided in the acute phase of viral myocarditis because they may increase the risk of viral replication and myocardial injury. Current evidence does not support the use of prednisone in acute viral myocarditis, and large trials have shown negative results in treating myocarditis with immunosuppressive therapy.</li><li>\u2022 Option D. Prednisone:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 In the management of acute viral myocarditis, Ramipril (an ACE inhibitor) is recommended to manage heart failure symptoms and improve cardiac function, while anti-inflammatory, immunosuppressive, and specific antiviral therapies are generally not recommended.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e428f5b",
      "audio": ""
    },
    {
      "text": "A 45-year-old man with a history of hypertension and hyperlipidemia presents with acute chest pain radiating to the left arm and jaw. ECG is shown. Which coronary artery is most likely occluded?",
      "options": [
        {
          "label": "A",
          "text": "Left anterior descending (LAD) artery",
          "correct": false
        },
        {
          "label": "B",
          "text": "Left circumflex (LCx) artery",
          "correct": false
        },
        {
          "label": "C",
          "text": "Right coronary artery (RCA)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Left main coronary artery",
          "correct": false
        }
      ],
      "correct_answer": "C. Right coronary artery (RCA)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-174647.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Left anterior descending (LAD) artery : Occlusion of the LAD artery typically causes ST-segment elevation in anterior leads.</li><li>\u2022 Option A. Left anterior descending (LAD) artery</li><li>\u2022 Option B. Left circumflex (LCx) artery : Occlusion of the LCx artery typically causes ST-segment elevation in lateral leads.</li><li>\u2022 Option B. Left circumflex (LCx) artery</li><li>\u2022 Option D. Left main coronary artery : Occlusion of the left main coronary artery typically causes widespread ST-segment elevation.</li><li>\u2022 Option D. Left main coronary artery</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Recognize the ECG findings of an inferior myocardial infarction and its association with RCA occlusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e661db92",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman presents with recurrent palpitations and near-syncope. ECG during the episode is shown. His BP is 130/84 mm Hg and PR is 154/min. Vagal manoeuvrers and IV adenosine (6mg) administration do not terminate the tachycardia. What is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Synchronized cardioversion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Repeat adenosine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Metoptolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amiodarone",
          "correct": false
        }
      ],
      "correct_answer": "B. Repeat adenosine",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-175001.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-175104.png"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Synchronized cardioversion: This is typically reserved for hemodynamically unstable patients or those who fail medical therapy.</li><li>\u2022 Option A. Synchronized cardioversion:</li><li>\u2022 Option C. Metoprolol: Beta-blockers like metoprolol (and calcium channel blockers) are used if initial therapy with vagal manoeuvres and adenosine fail.</li><li>\u2022 Option C. Metoprolol:</li><li>\u2022 Option D. Amiodarone: This is an antiarrhythmic drug that can be used if AV nodal blockers fail.</li><li>\u2022 Option D. Amiodarone:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Step wise management of regular narrow complex tachycardia (like AVNRT):</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e9d69291",
      "audio": ""
    },
    {
      "text": "A 23-year-old intern presents with recurrent episodes of syncope after hearing ambulance siren in the ER. She also experiences light-headedness and dizziness early morning once she wakes up hearing alarms. The ECG is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Brugada syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Congenital long QT syndrome",
          "correct": true
        },
        {
          "label": "C",
          "text": "Wolff-Parkinson-White syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypertrophic cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "B. Congenital long QT syndrome",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180215.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Brugada syndrome: This is associated with a specific ECG pattern (ST-elevation in V1-V3) and sudden cardiac death, not typically triggered by sounds.</li><li>\u2022 Option A. Brugada syndrome:</li><li>\u2022 Option C. Wolff-Parkinson-White syndrome: This involves an accessory pathway, causing a short PR interval and delta wave, and is not typically associated with syncope triggered by sound.</li><li>\u2022 Option C. Wolff-Parkinson-White syndrome:</li><li>\u2022 Option D. Hypertrophic cardiomyopathy: This is characterized by left ventricular hypertrophy, which may or may not have a prolonged QT interval and is not typically triggered by sound.</li><li>\u2022 Option D. Hypertrophic cardiomyopathy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Syncope triggered by auditory stimuli, combined with a prolonged QT interval on ECG, is highly suggestive of congenital long QT syndrome, particularly LQT2.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f921ba20",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman presents with abrupt-onset palpitations that she can terminate by coughing. ECG is shown. What is the most likely rhythm diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Atrial fibrillation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atrial tachycardia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atrioventricular nodal reentrant tachycardia (AVNRT)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ventricular tachycardia",
          "correct": false
        }
      ],
      "correct_answer": "C. Atrioventricular nodal reentrant tachycardia (AVNRT)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180707.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180802.png"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Atrial fibrillation: Irregular rhythm with no discernible P waves.</li><li>\u2022 Option A. Atrial fibrillation:</li><li>\u2022 Option B. Atrial tachycardia: Typically slower than AVNRT and less likely to be terminated by vagal maneuvers.</li><li>\u2022 Option B. Atrial tachycardia:</li><li>\u2022 Option D. Ventricular tachycardia: Wide QRS complex tachycardia.</li><li>\u2022 Option D. Ventricular tachycardia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 ECG findings of AVNRT = narrow QRS complex tachycardia, pseudo r' wave in V1, and responsiveness to vagal maneuvers.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4436b129",
      "audio": ""
    },
    {
      "text": "A 41-year-old man is evaluated for daily palpitations lasting minutes at a time. What is the most appropriate initial test?",
      "options": [
        {
          "label": "A",
          "text": "Exercise ECG",
          "correct": false
        },
        {
          "label": "B",
          "text": "30-day event monitor",
          "correct": false
        },
        {
          "label": "C",
          "text": "12-lead resting ECG",
          "correct": true
        },
        {
          "label": "D",
          "text": "24-hour ambulatory ECG monitor (Holter monitor)",
          "correct": false
        }
      ],
      "correct_answer": "C. 12-lead resting ECG",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Exercise ECG: Used to assess for exercise-induced arrhythmias or ischemia, not the initial test for palpitations.</li><li>\u2022 Option A. Exercise ECG:</li><li>\u2022 Option B. 30-day event monitor: Used for infrequent symptoms.</li><li>\u2022 Option B. 30-day event monitor:</li><li>\u2022 Option D. 24-hour Holter monitor: Indicated if the resting ECG is normal but suspicion for arrhythmia remains high.</li><li>\u2022 Option D. 24-hour Holter monitor:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The initial test in patients with a history of palpitations, presyncope, or syncope is 12-lead resting ECG.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9a5b50c",
      "audio": ""
    },
    {
      "text": "A 56-year-old woman with hypertension and hyperlipidemia is starting trastuzumab therapy for early-stage breast cancer. What is the most appropriate cardiac surveillance for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac MRI",
          "correct": false
        },
        {
          "label": "B",
          "text": "Echocardiography",
          "correct": true
        },
        {
          "label": "C",
          "text": "Multigated acquisition (MUGA) scan",
          "correct": false
        },
        {
          "label": "D",
          "text": "No surveillance",
          "correct": false
        }
      ],
      "correct_answer": "B. Echocardiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cardiac MRI: More expensive and not routinely needed for initial surveillance.</li><li>\u2022 Option A. Cardiac MRI:</li><li>\u2022 Option C. MUGA scan: Less commonly used for surveillance than echocardiography.</li><li>\u2022 Option C. MUGA scan:</li><li>\u2022 Option D. No surveillance: Inappropriate given the risk of cardiotoxicity with trastuzumab.</li><li>\u2022 Option D. No surveillance:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients receiving trastuzumab therapy at high risk for cardiac dysfunction, periodic echocardiographic surveillance is recommended.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "842560bb",
      "audio": ""
    },
    {
      "text": "A 78-year-old woman with HFrEF (EF 25%) presents with NYHA class III symptoms. She is currently receiving valsartan-sacubitril, carvedilol, spironolactone, empagliflozin, and furosemide. In view of persistent symptoms, she is planned for CRT. Which of the following is the most useful investigation in predicting the usefulness of CRT?",
      "options": [
        {
          "label": "A",
          "text": "ECG",
          "correct": true
        },
        {
          "label": "B",
          "text": "TEE",
          "correct": false
        },
        {
          "label": "C",
          "text": "SPECT",
          "correct": false
        },
        {
          "label": "D",
          "text": "PET",
          "correct": false
        }
      ],
      "correct_answer": "A. ECG",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. TEE (transesophageal echocardiography): While TEE can provide valuable information about cardiac structure and function, it is not the most reliable predictor of CRT response.</li><li>\u2022 Option B. TEE (transesophageal echocardiography):</li><li>\u2022 Option C. SPECT (single-photon emission computed tomography): SPECT can assess myocardial perfusion and viability but does not directly predict CRT response.</li><li>\u2022 Option C. SPECT (single-photon emission computed tomography):</li><li>\u2022 Option D. PET (positron emission tomography): PET is also used for myocardial viability assessment and is not the primary tool for predicting CRT response.</li><li>\u2022 Option D. PET (positron emission tomography):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understand that a 12-lead ECG demonstrating a wide QRS complex with LBBB morphology is the most useful investigation in predicting the potential benefits of CRT in patients with HFrEF.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0203a0be",
      "audio": ""
    },
    {
      "text": "A 50-year-old woman presents with chest pain that worsens with physical activity and improves with rest. Her resting ECG shows left ventricular hypertrophy (LVH) with a strain pattern. What is the most appropriate diagnostic test?",
      "options": [
        {
          "label": "A",
          "text": "Dobutamine echocardiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dobutamine myocardial perfusion imaging",
          "correct": false
        },
        {
          "label": "C",
          "text": "Exercise ECG",
          "correct": false
        },
        {
          "label": "D",
          "text": "Exercise myocardial perfusion imaging",
          "correct": true
        }
      ],
      "correct_answer": "D. Exercise myocardial perfusion imaging",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Dobutamine echocardiography: May be considered if the patient cannot exercise, but exercise is preferred.</li><li>\u2022 Option A. Dobutamine echocardiography:</li><li>\u2022 Option B. Dobutamine myocardial perfusion imaging : Can be used, but exercise is preferred if possible.</li><li>\u2022 Option B. Dobutamine myocardial perfusion imaging</li><li>\u2022 Option C. Exercise ECG: Less sensitive for detecting ischemia in patients with LVH due to baseline ECG changes.</li><li>\u2022 Option C. Exercise ECG:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Exercise myocardial perfusion imaging is the preferred stress test for assessing myocardial ischemia in patients with LVH.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37ccd95a",
      "audio": ""
    },
    {
      "text": "A 63-year-old woman is admitted to the ICU with respiratory failure. ECG is shown. Which of the following abnormalities is demonstrated on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Atrial fibrillation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atrial tachycardia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Multifocal atrial tachycardia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sinus tachycardia",
          "correct": false
        }
      ],
      "correct_answer": "C. Multifocal atrial tachycardia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-181657.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Atrial fibrillation: Has no P waves.</li><li>\u2022 Option A. Atrial fibrillation:</li><li>\u2022 Option B. Atrial tachycardia: Usually a regular rhythm and has single \u2018P\u2019 wave morphology</li><li>\u2022 Option B. Atrial tachycardia:</li><li>\u2022 Option D. Sinus tachycardia: Usually a regular rhythm and has single \u2018P\u2019 wave morphology</li><li>\u2022 Option D. Sinus tachycardia:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f6c54505",
      "audio": ""
    },
    {
      "text": "A 61-year-old man is evaluated following the recent diagnosis of hypertension. ECG is shown. Which of the following abnormalities is seen on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Accelerated idioventricular rhythm",
          "correct": false
        },
        {
          "label": "B",
          "text": "Left bundle branch block",
          "correct": true
        },
        {
          "label": "C",
          "text": "Old inferior myocardial infarction",
          "correct": false
        },
        {
          "label": "D",
          "text": "Right bundle branch block",
          "correct": false
        }
      ],
      "correct_answer": "B. Left bundle branch block",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-181851.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1f073e8b",
      "audio": ""
    },
    {
      "text": "A 58-year-old woman is evaluated prior to an elective total hip arthroplasty. ECG is shown. Which of the following abnormalities is seen on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Acute pericarditis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute anterior myocardial infarction",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nonacute inferior myocardial infarction",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acute lateral myocardial infarction",
          "correct": false
        }
      ],
      "correct_answer": "C. Nonacute inferior myocardial infarction",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182109.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 There are no ECG changes consistent with an anterior or lateral infarction.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "35e597fa",
      "audio": ""
    },
    {
      "text": "A 59-year-old man is evaluated following a transient ischemic attack. ECG is shown. Which of the following abnormalities is demonstrated on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Atrial fibrillation",
          "correct": true
        },
        {
          "label": "B",
          "text": "Atrial flutter",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atrioventricular nodal reentrant tachycardia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Atrioventricular reciprocating tachycardia",
          "correct": false
        }
      ],
      "correct_answer": "A. Atrial fibrillation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182316.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d1a8e0c",
      "audio": ""
    },
    {
      "text": "A 44-year-old man with a newly diagnosed ischemic stroke is evaluated in the emergency department. ECG is shown. Which of the following abnormalities is seen on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Left bundle branch block",
          "correct": false
        },
        {
          "label": "B",
          "text": "Left ventricular hypertrophy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Myocardial ischemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nonspecific intraventricular conduction delay",
          "correct": false
        }
      ],
      "correct_answer": "B. Left ventricular hypertrophy",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182500.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "40a41195",
      "audio": ""
    },
    {
      "text": "A 50-year-old woman is evaluated for palpitations. ECG is shown. Which of the following abnormalities is demonstrated on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Atrial fibrillation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atrial flutter",
          "correct": true
        },
        {
          "label": "C",
          "text": "Atrial tachycardia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sinus tachycardia",
          "correct": false
        }
      ],
      "correct_answer": "B. Atrial flutter",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182715.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "09a2362d",
      "audio": ""
    },
    {
      "text": "A 49-year-old man is evaluated for symptoms of dyspnea, peripheral edema, and exercise intolerance. Echocardiography shows biventricular increased wall thickness. ECG is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hypothyroidism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Infiltrative cardiomyopathy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pericardial effusion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stress-related cardiomyopathy",
          "correct": false
        }
      ],
      "correct_answer": "B. Infiltrative cardiomyopathy",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182906.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3648d99a",
      "audio": ""
    },
    {
      "text": "A 43-year-old man is evaluated for nonanginal chest pain. ECG is shown. Which of the following is shown on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Intraventricular conduction delay",
          "correct": false
        },
        {
          "label": "B",
          "text": "Left bundle branch block",
          "correct": false
        },
        {
          "label": "C",
          "text": "Right axis deviation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Right bundle branch block",
          "correct": true
        }
      ],
      "correct_answer": "D. Right bundle branch block",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183058.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0893224f",
      "audio": ""
    },
    {
      "text": "A 35-year-old man is evaluated for the acute onset of severe chest pain. ECG is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Arrhythmogenic right ventricular cardiomyopathy/dysplasia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Brugada syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pericarditis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "C. Pericarditis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183237.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7b4dac61",
      "audio": ""
    },
    {
      "text": "A 25-year-old man is evaluated for palpations and light headedness. ECG is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Antidromic atrioventricular reentrant tachycardia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atrial tachycardia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atrioventricular nodal reentrant tachycardia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sinus tachycardia",
          "correct": false
        }
      ],
      "correct_answer": "C. Atrioventricular nodal reentrant tachycardia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183439.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eaea6960",
      "audio": ""
    },
    {
      "text": "Mr. Karthik, is admitted to CCU after being diagnosed with STEMI. He received Reteplase an hour ago and currently he is asymptomatic and stable. The CCU staff nurse is concerned about the rhythm (shown below) in the monitor and informs you. What is the next step?",
      "options": [
        {
          "label": "A",
          "text": "Administer amiodarone 300mg mg IV",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer flecainide 400 mg orally",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer metoprolol 5 mg IV",
          "correct": false
        },
        {
          "label": "D",
          "text": "Continue observation",
          "correct": true
        }
      ],
      "correct_answer": "D. Continue observation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183627.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Administer amiodarone 300mg mg IV : Would be appropriate therapy if this was ventricular tachycardia or perhaps supraventricular tachycardia.</li><li>\u2022 Option A. Administer amiodarone 300mg mg IV</li><li>\u2022 Option B. Administer flecainide 400 mg orally : Class IC antiarrhythmic, contraindicated in post-MI patients due to increased mortality risk (CAST trial).</li><li>\u2022 Option B. Administer flecainide 400 mg orally</li><li>\u2022 Option C. Administer metoprolol 5 mg IV : Beta-blocker, may be used for rate control in certain SVTs but not indicated for AIVR.</li><li>\u2022 Option C. Administer metoprolol 5 mg IV</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Accelerated idioventricular rhythm, which commonly arises after reperfusion, is generally benign and transient. The slow rate is a major difference between accelerated idioventricular rhythm and ventricular tachycardia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf9202f4",
      "audio": ""
    },
    {
      "text": "A 56-year-old man is evaluated for bradycardia prior to cataract surgery. He is asymptomatic. ECG is shown. Which of the following ECG findings is present?",
      "options": [
        {
          "label": "A",
          "text": "Mobitz type 1 second-degree atrioventricular block",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mobitz type 2 second-degree atrioventricular block",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sinus arrest",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sinus bradycardia",
          "correct": true
        }
      ],
      "correct_answer": "D. Sinus bradycardia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184015.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "168f2272",
      "audio": ""
    },
    {
      "text": "A 47-year-old woman with sarcoidosis is evaluated for an irregular pulse, a sensation of pounding in the neck, and an episode of syncope. ECG is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Junctional rhythm",
          "correct": false
        },
        {
          "label": "B",
          "text": "Monomorphic ventricular tachycardia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Polymorphic ventricular tachycardia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ventricular fibrillation",
          "correct": false
        }
      ],
      "correct_answer": "B. Monomorphic ventricular tachycardia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184202.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b43391c4",
      "audio": ""
    },
    {
      "text": "A 34-year-old woman is evaluated for unexplained right heart enlargement and a history of paroxysmal atrial fibrillation. Physical examination reveals a parasternal impulse, fixed splitting of S2, mitral regurgitation, and a pulmonary outflow murmur. ECG is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Ostium primum atrial septal defect",
          "correct": true
        },
        {
          "label": "B",
          "text": "Patent ductus arteriosus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Patent foramen ovale",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ventricular septal defect",
          "correct": false
        }
      ],
      "correct_answer": "A. Ostium primum atrial septal defect",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184317.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "207d1160",
      "audio": ""
    },
    {
      "text": "A 64-year-old woman is evaluated in the emergency department following an episode of syncope. ECG is shown. Which of the following abnormalities is demonstrated on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Atrial tachycardia with 2:1 block",
          "correct": false
        },
        {
          "label": "B",
          "text": "Complete heart block",
          "correct": false
        },
        {
          "label": "C",
          "text": "Junctional rhythm",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mobitz type 2 second-degree atrioventricular block",
          "correct": false
        }
      ],
      "correct_answer": "C. Junctional rhythm",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184453.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e9e9aeb0",
      "audio": ""
    },
    {
      "text": "A 35-year-old man is evaluated in the emergency department for rapid heart rate and dizziness. He was recently started on levofloxacin for community-acquired pneumonia. A telemetry rhythm strip is shown. Which of the following abnormalities is seen on this patient's telemetry rhythm strip?",
      "options": [
        {
          "label": "A",
          "text": "Monomorphic ventricular tachycardia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Right bundle branch block with aberrancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Torsades de pointes",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ventricular fibrillation",
          "correct": false
        }
      ],
      "correct_answer": "C. Torsades de pointes",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184630.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "322bbaa5",
      "audio": ""
    },
    {
      "text": "A 48-year-old woman is evaluated for dyspnea associated with nausea and diaphoresis. ECG is shown. Which of the following abnormalities is demonstrated on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Early repolarization",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inferior myocardial infarction",
          "correct": true
        },
        {
          "label": "C",
          "text": "Non\u2013ST-elevation myocardial infarction",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pericarditis",
          "correct": false
        }
      ],
      "correct_answer": "B. Inferior myocardial infarction",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184819.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6a980120",
      "audio": ""
    },
    {
      "text": "A 25-year-old woman is evaluated for a \u201cracing heart\u201d sensation. ECG is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Atrial tachycardia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atrioventricular nodal reentrant tachycardia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atrioventricular reciprocating tachycardia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sinus tachycardia",
          "correct": true
        }
      ],
      "correct_answer": "D. Sinus tachycardia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185004.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f4bb99fb",
      "audio": ""
    },
    {
      "text": "A 23-year-old woman is evaluated for recurrent episodes of syncope. She is otherwise well and takes no medications. ECG is shown. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Brugada syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypertrophic cardiomyopathy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Long QT syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Neurocardiogenic syncope",
          "correct": false
        }
      ],
      "correct_answer": "C. Long QT syndrome",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185143.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dd2736ef",
      "audio": ""
    },
    {
      "text": "A 79-year-old woman is evaluated for fatigue and bradycardia. ECG is shown. Which of the following abnormalities is seen on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Idioventricular rhythm",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mobitz type 2 second-degree heart block",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sinus bradycardia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Third-degree heart block",
          "correct": true
        }
      ],
      "correct_answer": "D. Third-degree heart block",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185318.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2c6f6b6c",
      "audio": ""
    },
    {
      "text": "A 31-year-old woman is evaluated for episodes of palpitations. ECG is shown. Which of the following abnormalities or underlying conditions is responsible for the changes on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Atrial septal defect",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lown-Ganong-Levine pattern",
          "correct": false
        },
        {
          "label": "C",
          "text": "Patent foramen ovale",
          "correct": false
        },
        {
          "label": "D",
          "text": "Wolff-Parkinson-White pattern",
          "correct": true
        }
      ],
      "correct_answer": "D. Wolff-Parkinson-White pattern",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185505.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b4296a1e",
      "audio": ""
    },
    {
      "text": "A 51-year-old man is evaluated for syncope after prolonged standing in a warm environment. ECG is shown. Which of the following ECG findings is shown?",
      "options": [
        {
          "label": "A",
          "text": "First-degree atrioventricular block",
          "correct": true
        },
        {
          "label": "B",
          "text": "Normal sinus rhythm",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sick sinus syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sinoatrial nodal exit block",
          "correct": false
        }
      ],
      "correct_answer": "A. First-degree atrioventricular block",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185636.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2345f4fb",
      "audio": ""
    },
    {
      "text": "A 57-year-old woman with peripheral artery disease is evaluated prior to elective cholecystectomy. ECG is shown. Which of the following is the most likely electrocardiographic diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Bifascicular block conduction delay",
          "correct": false
        },
        {
          "label": "B",
          "text": "Left anterior fascicular block",
          "correct": false
        },
        {
          "label": "C",
          "text": "Left posterior fascicular block",
          "correct": true
        },
        {
          "label": "D",
          "text": "Right bundle branch block",
          "correct": false
        }
      ],
      "correct_answer": "C. Left posterior fascicular block",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185806.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fd89be17",
      "audio": ""
    },
    {
      "text": "Which of the following conditions is demonstrated on this electrocardiogram?",
      "options": [
        {
          "label": "A",
          "text": "Acute posterior myocardial infarction",
          "correct": false
        },
        {
          "label": "B",
          "text": "Brugada pattern",
          "correct": false
        },
        {
          "label": "C",
          "text": "Left ventricular hypertrophy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Right ventricular hypertrophy",
          "correct": true
        }
      ],
      "correct_answer": "D. Right ventricular hypertrophy",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185926.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a302cb38",
      "audio": ""
    },
    {
      "text": "Which of the following is the most likely cause of the findings on this electrocardiogram?",
      "options": [
        {
          "label": "A",
          "text": "Hypercalcemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperkalemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypocalcemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hypothermia",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypocalcemia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190037.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "703d7ee7",
      "audio": ""
    },
    {
      "text": "A 25-year-old woman experiences intermittent palpitations, shortness of breath, and light headedness. ECG is shown. Echocardiogram is normal. What is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Atenolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Electrophysiology (EP) study",
          "correct": true
        },
        {
          "label": "C",
          "text": "Flecainide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Verapamil",
          "correct": false
        }
      ],
      "correct_answer": "B. Electrophysiology (EP) study",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190157.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Options A. Atenolol and D. Verapamil (AV nodal blockers): These medications are atrioventricular nodal blockers and may be unsafe if the patient has anterograde conduction down the accessory pathway during atrial fibrillation. These drugs promote rapid 1:1 conduction from the atria to the ventricles over the accessory pathway during atrial fibrillation, which can lead to very rapid ventricular rates and ventricular fibrillation.</li><li>\u2022 Options A. Atenolol and D. Verapamil (AV nodal blockers):</li><li>\u2022 Option C. Flecainide: It is an antiarrhythmic drug that is frequently used to treat paroxysmal atrial fibrillation and other arrhythmias. Flecainide is not indicated in this patient because the type and mechanism of the arrhythmia are unknown. This patient requires risk stratification, which can be accomplished with an electrophysiology study.</li><li>\u2022 Option C. Flecainide:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In patients with suspected WPW syndrome, an EP study is indicated to assess arrhythmia risk and consider ablation of the accessory pathway.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "03f803c6",
      "audio": ""
    },
    {
      "text": "An 81-year-old man with a history of hypertension and osteoarthritis is scheduled for elective hip arthroplasty. He is asymptomatic and has no history of cardiovascular disease. His ECG is shown. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Dobutamine echocardiography",
          "correct": false
        },
        {
          "label": "B",
          "text": "Echocardiography",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prophylactic pacemaker insertion",
          "correct": false
        },
        {
          "label": "D",
          "text": "No further testing or intervention",
          "correct": true
        }
      ],
      "correct_answer": "D. No further testing or intervention",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190419.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Dobutamine echocardiography: Not indicated as there are no signs or symptoms of heart failure or ischemia.</li><li>\u2022 Option A. Dobutamine echocardiography:</li><li>\u2022 Option B. Echocardiography: Not necessary as the ECG findings are not suggestive of structural heart disease.</li><li>\u2022 Option B. Echocardiography:</li><li>\u2022 Option C. Prophylactic pacemaker insertion: Not indicated in asymptomatic patients with bifascicular block and first-degree AV block.</li><li>\u2022 Option C. Prophylactic pacemaker insertion:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Asymptomatic Tri-fascicular block does not require pacemaker implantation</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3851699a",
      "audio": ""
    },
    {
      "text": "An 84-year-old man presents with fatigue and loss of energy. His ECG is shown. Upon vigorous exercise his heart rate reaches a maximum of 72/min. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Hospital admission",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pacemaker implantation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Switch lisinopril to amlodipine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reassurance and clinical monitoring",
          "correct": false
        }
      ],
      "correct_answer": "B. Pacemaker implantation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-091643.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hospital admission: Not necessary unless the patient is hemodynamically unstable.</li><li>\u2022 Option A. Hospital admission:</li><li>\u2022 Option C. Switching medications: Unlikely to address the underlying bradycardia.</li><li>\u2022 Option C. Switching medications:</li><li>\u2022 Option D. Reassurance and monitoring: Inadequate for symptomatic bradycardia with potential for adverse outcomes.</li><li>\u2022 Option D. Reassurance and monitoring:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Treat a patient with symptomatic bradycardia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "05293df6",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with history of hypertension and stroke has been diagnosed with mildly symptomatic paroxysmal AF. He is currently taking rivaroxaban and metoprolol. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Left atrial appendage occlusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pacemaker implantation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rhythm control",
          "correct": true
        },
        {
          "label": "D",
          "text": "No additional therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Rhythm control",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Left atrial appendage occlusion: Indicated for stroke prevention in non-valvular AF but not the primary treatment for rhythm control.</li><li>\u2022 Option A. Left atrial appendage occlusion:</li><li>\u2022 Option B. Pacemaker implantation: Not indicated for paroxysmal AF without symptomatic bradycardia.</li><li>\u2022 Option B. Pacemaker implantation:</li><li>\u2022 Option D. No additional therapy: Early rhythm control is recommended for this patient.</li><li>\u2022 Option D. No additional therapy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with recently diagnosed atrial fibrillation and concomitant cardiovascular conditions, early rhythm control (antiarrhythmic drugs or ablation) reduces the primary composite end point of cardiovascular death, stroke, or hospitalization for heart failure or acute coronary syndrome compared with usual care.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2af02816",
      "audio": ""
    },
    {
      "text": "A 56-year-old man with hypertension presents with acute shortness of breath, hypotension and palpitations. He has jugular venous distention and pulmonary crackles. ECG was done and is shown below. After successful cardioversion, what is the best treatment?",
      "options": [
        {
          "label": "A",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Catheter ablation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Flecainide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metoprolol",
          "correct": false
        }
      ],
      "correct_answer": "B. Catheter ablation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-091936.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Amiodarone: Antiarrhythmic drug that can be used for atrial flutter, but catheter ablation is more definitive.</li><li>\u2022 Option A. Amiodarone:</li><li>\u2022 Option C. Flecainide: Another antiarrhythmic drug, but catheter ablation is preferred.</li><li>\u2022 Option C. Flecainide:</li><li>\u2022 Option D. Metoprolol: Beta-blocker, primarily used for rate control, not as effective for rhythm control in atrial flutter.</li><li>\u2022 Option D. Metoprolol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Catheter ablation is the definitive treatment for typical atrial flutter due to its high success rate and low complication rate.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7543ef34",
      "audio": ""
    },
    {
      "text": "A 26-year-old woman presents with recurrent palpitations lasting 5-15 minutes, occue a few times per month and relieved by rest or deep breathing. The resting ECG is normal. What is the most appropriate diagnostic test?",
      "options": [
        {
          "label": "A",
          "text": "Exercise ECG",
          "correct": false
        },
        {
          "label": "B",
          "text": "Implantable loop recorder",
          "correct": false
        },
        {
          "label": "C",
          "text": "Holter Monitoring",
          "correct": false
        },
        {
          "label": "D",
          "text": "30-day event monitor",
          "correct": true
        }
      ],
      "correct_answer": "D. 30-day event monitor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Exercise ECG: Not indicated for evaluating palpitations occurring at rest.</li><li>\u2022 Option A. Exercise ECG:</li><li>\u2022 Option B. Implantable loop recorder: Reserved for very infrequent or unexplained syncope (which prevents the patient from triggering the devices). Records symptomatic and asymptomatic events (brady/tachy) over a very long period (months to years).</li><li>\u2022 Option B. Implantable loop recorder:</li><li>\u2022 Option C. Holter monitoring :  Usually records electrical activity continuously for 24-28 hours and most suited for patients with more frequent symptoms (e.g., daily).</li><li>\u2022 Option C. Holter monitoring</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A 30-day event monitor is most appropriate for evaluating patients with palpitations who have symptoms that occur less than daily but frequently over the course of a month.</li><li>\u27a4 An implantable looping event recorder is most appropriate for infrequent or highly symptomatic arrhythmias in which the symptoms might preclude a patient from activating the device, such as syncope.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5dc44cd1",
      "audio": ""
    },
    {
      "text": "A 25-year-old man presents with recurrent syncope without prodrome. His father died suddenly at age 45. ECG is shown. Physical examination and 2D Echo is normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Brugada syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Coronary artery disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Long QT syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vasovagal syncope",
          "correct": false
        }
      ],
      "correct_answer": "A. Brugada syndrome",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092311.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Coronary artery disease: Unlikely in a young patient with no risk factors and normal ECG findings.</li><li>\u2022 Option B. Coronary artery disease:</li><li>\u2022 Option C. Long QT syndrome: ECG would show a prolonged QT interval, not the Brugada pattern.</li><li>\u2022 Option C. Long QT syndrome:</li><li>\u2022 Option D. Vasovagal syncope: Typically has prodromal symptoms (lightheadedness, nausea) and normal ECG.</li><li>\u2022 Option D. Vasovagal syncope:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cardiovascular syncopal events often occur suddenly and usually without a significant prodrome, although chest pain and palpitations may be present.</li><li>\u27a4 Causes of cardiovascular syncope include cardiac arrhythmia; coronary artery disease; and structural and obstructive disease, including aortic and pulmonary valve stenosis, obstructive hypertrophic cardiomyopathy, aortic dissection, and cardiac tamponade.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8840e52f",
      "audio": ""
    },
    {
      "text": "A 76-year-old woman presents with palpitations. Her ECG is shown. She is a known diabetic and hypertensive and currently taking metformin and metoprolol. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Add aspirin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase metoprolol dose",
          "correct": false
        },
        {
          "label": "C",
          "text": "Initiate oral anticoagulation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Reassurance",
          "correct": false
        }
      ],
      "correct_answer": "C. Initiate oral anticoagulation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092619.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Aspirin: Insufficient for stroke prevention in high-risk patients.</li><li>\u2022 Option A. Aspirin:</li><li>\u2022 Option B. Increase metoprolol dosage: Not necessary as the ventricular rate is controlled.</li><li>\u2022 Option B. Increase metoprolol dosage:</li><li>\u2022 Option D. Reassurance: Inappropriate as the patient is at high risk for stroke.</li><li>\u2022 Option D. Reassurance:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In stable patients with atrial fibrillation, the primary goals of therapy are to (1) prevent stroke, (2) control heart rate, (3) minimize or eliminate symptoms, and (4) modify underlying risk factors.</li><li>\u27a4 Anticoagulation is indicated for stroke prevention in patients with nonvalvular atrial fibrillation who have a CHA2DS2-VASc score of 2 or greater in men or 3 or greater in women.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8797b25",
      "audio": ""
    },
    {
      "text": "A 42-year-old man presents with palpitations and lightheadedness. He was having significant work pressure over the last 2 weeks and he has not been sleeping well. ECG showed VT and he is successfully cardioverted in the ER. Echocardiogram is normal. What is the most appropriate initial management?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac MRI with stress perfusion",
          "correct": true
        },
        {
          "label": "B",
          "text": "Electrophysiology (EP) study",
          "correct": false
        },
        {
          "label": "C",
          "text": "Implantable cardioverter-defibrillator (ICD)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Implantable loop recorder (ILR)",
          "correct": false
        }
      ],
      "correct_answer": "A. Cardiac MRI with stress perfusion",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. EP study: May be indicated later if diagnosis of sustained VT is in doubt or if ablation is being considered (to localize the arrhythmogenic focus).</li><li>\u2022 Option B. EP study:</li><li>\u2022 Option C. ICD: May be considered if there is VT + structural heart disease or HF with EF \u2264 35%. In idiopathic VT, it is unnecessary.</li><li>\u2022 Option C. ICD:</li><li>\u2022 Option D. ILR: It would be premature to consider ILR placement before assessment for structural heart disease. An ILR may be valuable to assess rare recurrences of arrhythmia and/or to assess symptoms, but further evaluation is needed first.</li><li>\u2022 Option D. ILR:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cardiac MRI with stress perfusion is a valuable tool for evaluating the underlying cause of VT in patients with structurally normal hearts on echocardiography.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e30f0dd3",
      "audio": ""
    },
    {
      "text": "A 36-year-old man is evaluated in the emergency department for an irregular heart rhythm. He is otherwise asymptomatic. A representative sample from an ECG rhythm strip is shown. Which of the following abnormalities is seen on this patient's ECG?",
      "options": [
        {
          "label": "A",
          "text": "Complete heart block",
          "correct": false
        },
        {
          "label": "B",
          "text": "High-grade atrioventricular block",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mobitz type 1 second-degree atrioventricular block",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mobitz type 2 second-degree atrioventricular block",
          "correct": false
        }
      ],
      "correct_answer": "C. Mobitz type 1 second-degree atrioventricular block",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092929.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This ECG demonstrates Mobitz type 1 second-degree (Wenckebach) atrioventricular block, which is characterized electrocardiographically by a PR interval that progressively prolongs until, eventually, the beat is dropped. In the tracing shown, the PR interval widens over the first six beats and no ventricular complex follows the seventh atrial beat.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "342b5bfb",
      "audio": ""
    },
    {
      "text": "An 81-year-old man is evaluated in the emergency department for chest pain. During the evaluation, he becomes unresponsive and pulseless. ECG is shown. what is the next best step in the management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Administer 100% oxygen by NRBM",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer procainamide IV",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer 1 g calcium gluconate IV",
          "correct": false
        },
        {
          "label": "D",
          "text": "Unsynchronized defibrillation with 200 J",
          "correct": true
        }
      ],
      "correct_answer": "D. Unsynchronized defibrillation with 200 J",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093042.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This patient is in ventricular fibrillation. Immediate defibrillation  is required and treatment should proceed along advanced cardiac life support protocol. Defibrillation in this case should precede administration of oxygen. Medications will not be effective in the absence of circulation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e5f59a5f",
      "audio": ""
    },
    {
      "text": "Which of the following disorders could account for the findings on the rhythm strip of a homeless man who was found unresponsive on the street?",
      "options": [
        {
          "label": "A",
          "text": "Hypocalcemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypokalemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypophosphatemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypothermia",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypothermia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093143.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093206.png"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Hypothermia most likely accounts for the findings shown on this electrocardiogram. In hypothermia, all of the electrocardiographic intervals are prolonged, including the PR interval, the QRS complex, the QT interval, and the R-R interval, owing to slowed impulse conduction through potassium channels. In addition, the J point is elevated, producing a characteristic J wave (Osborn wave) that represents distortion of the earliest phase of membrane repolarization. These changes are most prominent in the precordial leads V2 through V5. This electrocardiogram demonstrates Osborn waves (arrows).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "394f4df1",
      "audio": ""
    },
    {
      "text": "Which of the following diagnoses is most consistent with the radiographic findings shown?",
      "options": [
        {
          "label": "A",
          "text": "Dual chamber Pacemaker",
          "correct": true
        },
        {
          "label": "B",
          "text": "Single chamber pacemaker",
          "correct": false
        },
        {
          "label": "C",
          "text": "CRT device",
          "correct": false
        },
        {
          "label": "D",
          "text": "Swan Ganz catheter",
          "correct": false
        }
      ],
      "correct_answer": "A. Dual chamber Pacemaker",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-112453.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Single chamber pacemaker: A single chamber pacemaker has only one lead, typically in the RV.</li><li>\u2022 Option</li><li>\u2022 B. Single chamber pacemaker:</li><li>\u2022 Option C. CRT device: A CRT device would include an additional lead positioned to pace the left ventricle via the coronary sinus, which is not seen in this image.</li><li>\u2022 Option C. CRT device:</li><li>\u2022 Option D. Swan Ganz catheter: A Swan-Ganz catheter, used for measuring hemodynamic parameters, is not an implantable device and would appear as a different configuration on imaging.</li><li>\u2022 Option D. Swan Ganz catheter:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A dual chamber pacemaker has leads placed in both the right atrium and right ventricle. This device is used to maintain coordinated atrial and ventricular pacing in patients with specific types of heart block or other cardiac rhythm disturbances.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bc22bd02",
      "audio": ""
    },
    {
      "text": "A 50-year-old gentleman presents with complaints of dizziness and one episode of syncope. On examination, you notice a pulse rate of around 38/min and blood pressure of approximately 88/56 mmHg. What will be your next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Urgent transcutaneous pacing",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urgent transvenous pacing",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atropine 0.5 mg IV push",
          "correct": true
        },
        {
          "label": "D",
          "text": "Emergency defibrillation",
          "correct": false
        }
      ],
      "correct_answer": "C. Atropine 0.5 mg IV push",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/picture1.jpg"
      ],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Urgent transcutaneous pacing: While TCP may be necessary if atropine is ineffective or if the bradycardia is due to complete heart block, it is not the initial treatment of choice in this situation.</li><li>\u2022 Option A.</li><li>\u2022 Urgent transcutaneous pacing:</li><li>\u2022 Option B. Urgent transvenous pacing: Similar to TCP, transvenous pacing is a more definitive treatment but is not the immediate priority in an unstable patient.</li><li>\u2022 Option B. Urgent transvenous pacing:</li><li>\u2022 Option D. Emergency defibrillation: Defibrillation is indicated for ventricular fibrillation or pulseless ventricular tachycardia, not for bradycardia with a pulse.</li><li>\u2022 Option D. Emergency defibrillation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Symptomatic bradycardia with hemodynamic instability is a medical emergency. Initial treatment as per ACLS protocol is atropine administration.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c3b3bb52",
      "audio": ""
    },
    {
      "text": "All of the following are true regarding Mobitz II block except?",
      "options": [
        {
          "label": "A",
          "text": "PR varying",
          "correct": true
        },
        {
          "label": "B",
          "text": "Wide QRS",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bundle branch block",
          "correct": false
        },
        {
          "label": "D",
          "text": "Defect lies below AV node",
          "correct": false
        }
      ],
      "correct_answer": "A. PR varying",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Wide QRS: This is often present in Mobitz II due to the block occurring below the AV node, affecting the His-Purkinje system.</li><li>\u2022 Option B. Wide QRS:</li><li>\u2022 Option C. Bundle branch block: Mobitz II is frequently associated with bundle branch block as the block occurs within the bundle branches or more distally in the conduction system.</li><li>\u2022 Option C. Bundle branch block:</li><li>\u2022 Option D. Defect lies below AV node: The conduction defect in Mobitz II is located below the AV node, typically in the His-Purkinje system.</li><li>\u2022 Option D. Defect lies below AV node:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mobitz II second-degree block is associated with a constant PR interval, wide QRS complex and bundle branch block due to the conduction defect located below the AV node.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4c3fd67f",
      "audio": ""
    },
    {
      "text": "A 30-year-old male presents with palpitations and giddiness for 2 hours. On arrival, BP is 80/60 mmHg. ECG is shown. What is the next step in management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Carotid sinus massage",
          "correct": false
        },
        {
          "label": "B",
          "text": "Adenosine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cardioversion",
          "correct": true
        },
        {
          "label": "D",
          "text": "IV metoprolol",
          "correct": false
        }
      ],
      "correct_answer": "C. Cardioversion",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093714.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/picture2.jpg"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Carotid sinus massage: This maneuver can sometimes terminate AVNRT, but it is not recommended in the setting of hemodynamic instability due to the risk of further complications.</li><li>\u2022 Option A. Carotid sinus massage:</li><li>\u2022 Option B. Adenosine: Adenosine is a first-line agent for stable AVNRT, but it is contraindicated in patients with asthma or bronchospasm and may not be effective in cases of hemodynamic instability.</li><li>\u2022 Option B. Adenosine:</li><li>\u2022 Option D. IV metoprolol: Beta-blockers like metoprolol are used for rate control in AVNRT, but they should not be the initial treatment in hemodynamically unstable patients.</li><li>\u2022 Option D. IV metoprolol:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 \u2018 If the patient is in shock, shock the patient !\u2019</li><li>\u27a4 \u2018</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a3ce048c",
      "audio": ""
    },
    {
      "text": "A pregnant lady G2P1L1 currently 37 weeks POG (period of gestation) presented with worsening headache, blurring of vision, reduced perception of fetal movements. On arrival, BP was 200/100 mmHg. ECG is shown. Which of the following is the best management?",
      "options": [
        {
          "label": "A",
          "text": "IV MgSO4",
          "correct": true
        },
        {
          "label": "B",
          "text": "IV lignocaine",
          "correct": false
        },
        {
          "label": "C",
          "text": "IV amiodarone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Defibrillation",
          "correct": false
        }
      ],
      "correct_answer": "A. IV MgSO4",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093914.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. IV lignocaine: While lidocaine is an antiarrhythmic, it is not effective in PMVT.</li><li>\u2022 Option B. IV lignocaine:</li><li>\u2022 Option C. IV amiodarone: Amiodarone is effective for monomorphic VT but can prolong QTc interval and potentially can trigger PMVT.</li><li>\u2022 Option C. IV amiodarone:</li><li>\u2022 Option D. Defibrillation: Can be tried in case of unstable PMVT or if the patient is in cardiac arrest.</li><li>\u2022 Option D. Defibrillation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 IV MgSO4 is the treatment of choice for stable PMVT.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "924b6550",
      "audio": ""
    },
    {
      "text": "A 44-year-old patient with HCM presents with palpitations over the last 1 week. ECG showed AF. His CHA2DS2-Vasc score is 0. What is the treatment?",
      "options": [
        {
          "label": "A",
          "text": "No anticoagulation required",
          "correct": false
        },
        {
          "label": "B",
          "text": "Warfarin for 4 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "Long term Warfarin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anticoagulation is contraindicated",
          "correct": false
        }
      ],
      "correct_answer": "C. Long term Warfarin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. No anticoagulation required: This is incorrect as anticoagulation is strongly recommended for HCM patients with AF.</li><li>\u2022 Option A. No anticoagulation required:</li><li>\u2022 Option B. Warfarin for 4 weeks: This is insufficient duration. Long-term anticoagulation is necessary for stroke prevention in HCM patients with AF.</li><li>\u2022 Option B. Warfarin for 4 weeks:</li><li>\u2022 Option D. Anticoagulation contraindicated: This is incorrect. Anticoagulation is indicated for stroke prevention in HCM patients with AF.</li><li>\u2022 Option D. Anticoagulation contraindicated:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF), long-term anticoagulation is recommended regardless of their CHA2DS2-VASc score due to the increased risk of thromboembolic events.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc5efd65",
      "audio": ""
    },
    {
      "text": "A 71-year-old man with a pacemaker presents with malaise, fatigue, and localized discomfort at the pacemaker site and the appearance is shown in the image. He has no fever, chills, or weight loss. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Blood cultures",
          "correct": true
        },
        {
          "label": "B",
          "text": "Empiric therapy with cephalexin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pacemaker pocket aspiration",
          "correct": false
        },
        {
          "label": "D",
          "text": "PET/CT scanning",
          "correct": false
        }
      ],
      "correct_answer": "A. Blood cultures",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-094129.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Empiric therapy with cephalexin: Premature before confirming infection and identifying the causative organism.</li><li>\u2022 Option B. Empiric therapy with cephalexin:</li><li>\u2022 Option C. Pacemaker pocket aspiration: Not recommended as it can introduce infection into a previously sterile pocket.</li><li>\u2022 Option C. Pacemaker pocket aspiration:</li><li>\u2022 Option D. PET/CT scanning: May be helpful later if the diagnosis is unclear, but blood cultures are the priority.</li><li>\u2022 Option D. PET/CT scanning:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In all patients suspected of having infection of a cardiac implanted electronic device, a minimum of two blood cultures should be drawn from separate sites.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b0832db8",
      "audio": ""
    },
    {
      "text": "A 75-year-old patient with long-standing atrial fibrillation (AF) received a VVIR pacemaker. After a few months, he presents with dizziness, fatigue, and visible pulsations in the neck. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Sick sinus syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pacemaker syndrome",
          "correct": true
        },
        {
          "label": "C",
          "text": "Lead displacement",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ventricular tachycardia",
          "correct": false
        }
      ],
      "correct_answer": "B. Pacemaker syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Sick sinus syndrome: Would not be associated with elevated JVP or cannon \u2018a\u2019 waves.</li><li>\u2022 Option A. Sick sinus syndrome:</li><li>\u2022 Option C. Lead displacement: Lead displacement would likely cause pacing failure or erratic pacing, not the specific symptoms described.</li><li>\u2022 Option C. Lead displacement:</li><li>\u2022 Option D. Ventricular tachycardia: This would present with a rapid, regular heart rhythm and different symptoms (palpitations, chest pain, syncope).</li><li>\u2022 Option D. Ventricular tachycardia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pacemaker syndrome is a potential complication of single-chamber ventricular pacing (usually VVIR), and presents with dizziness and syncope due to AV dissociation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8dbb66dd",
      "audio": ""
    },
    {
      "text": "What is the most common mechanism of digitalis-induced ventricular arrhythmias?",
      "options": [
        {
          "label": "A",
          "text": "Re-entry",
          "correct": false
        },
        {
          "label": "B",
          "text": "Delayed afterdepolarizations (DADs)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Early afterdepolarizations (EADs)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Enhanced automaticity",
          "correct": false
        }
      ],
      "correct_answer": "B. Delayed afterdepolarizations (DADs)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Re-entry: While re-entry is the most common mechanism for arrhythmias in general, it's not the primary mechanism for digitalis-induced ventricular arrhythmias.</li><li>\u2022 Option A. Re-entry:</li><li>\u2022 Option C. Early afterdepolarizations (EADs): EADs are associated with prolonged repolarization (long QT syndrome), which is not a direct effect of digitalis toxicity.</li><li>\u2022 Option C. Early afterdepolarizations (EADs):</li><li>\u2022 Option D. Enhanced automaticity: Although digitalis can increase automaticity, it's not the predominant mechanism; DADs caused by calcium overload play a more significant role.</li><li>\u2022 Option D. Enhanced automaticity:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Understand that the primary mechanism of digitalis-induced ventricular arrhythmias is delayed afterdepolarizations (DADs) caused by intracellular calcium overload.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8600cb02",
      "audio": ""
    },
    {
      "text": "Which of the following describes the AV node accurately?",
      "options": [
        {
          "label": "A",
          "text": "Decremental response",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sodium-dependent conduction",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased gap junctions",
          "correct": false
        },
        {
          "label": "D",
          "text": "Speed of conduction is 1-2 m/s",
          "correct": false
        }
      ],
      "correct_answer": "A. Decremental response",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Sodium-dependent conduction: The action potential upstroke in the AV node is dependent on the smaller and slower inward Ca2+ current, which is the reason why the upstroke velocity of the action potential is low\u2014one of the factors responsible for the slow conduction velocity in the AV node.</li><li>\u2022 Option B. Sodium-dependent conduction:</li><li>\u2022 Option C. Increased gap junctions: The AV node actually has fewer gap junctions than other parts of the conduction system, contributing to its slower conduction speed.</li><li>\u2022 Option C. Increased gap junctions:</li><li>\u2022 Option D. Speed of conduction is 1-2 m/s: The conduction speed in the AV node is much slower, around 0.05 m/s (50 mm/s).</li><li>\u2022 Option D. Speed of conduction is 1-2 m/s:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 AV node acts as a \u2018gatekeeper\u2019 to the ventricles.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "61788288",
      "audio": ""
    },
    {
      "text": "You are seeing Mr. Aravind, a 24-year-old previously healthy athlete, for his routine physical examination. Which of the following rhythms is demonstrated?",
      "options": [
        {
          "label": "A",
          "text": "First-degree heart block",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mobitz type I, second-degree heart block",
          "correct": true
        },
        {
          "label": "C",
          "text": "Mobitz type II, second-degree heart block",
          "correct": false
        },
        {
          "label": "D",
          "text": "Complete Heart Block",
          "correct": false
        }
      ],
      "correct_answer": "B. Mobitz type I, second-degree heart block",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-094521.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. First-degree heart block: This has a prolonged but constant PR interval.</li><li>\u2022 Option A. First-degree heart block:</li><li>\u2022 Option C. Mobitz type II, second-degree heart block: This has a constant PR interval with occasional dropped QRS complexes.</li><li>\u2022 Option C. Mobitz type II, second-degree heart block:</li><li>\u2022 Option D. Type III heart block (complete heart block): This has complete dissociation between the atria and ventricles, with no relationship between P waves and QRS complexes.</li><li>\u2022 Option D. Type III heart block (complete heart block):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mobitz type I second-degree heart block (Wenckebach) is a relatively benign rhythm often seen in athletes due to high vagal tone.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e520743",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT indicative of high risk in Wolff-Parkinson-White (WPW) syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Multiple pathways",
          "correct": false
        },
        {
          "label": "B",
          "text": "Refractory period > 240 ms",
          "correct": true
        },
        {
          "label": "C",
          "text": "Inducible AF or AVRT",
          "correct": false
        },
        {
          "label": "D",
          "text": "Accessory pathway in the posteroseptal region",
          "correct": false
        }
      ],
      "correct_answer": "B. Refractory period > 240 ms",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Multiple pathways: The presence of multiple accessory pathways increases the risk of arrhythmias and is a high-risk feature.</li><li>\u2022 Option A. Multiple pathways:</li><li>\u2022 Option C. Inducible AF or AVRT: The ability to induce AF or AV reentrant tachycardia (AVRT) during electrophysiology study indicates a higher risk of spontaneous arrhythmias and is a high-risk feature.</li><li>\u2022 Option C. Inducible AF or AVRT:</li><li>\u2022 Option D. Accessory pathway in the posteroseptal region: Poster septal accessory pathways are associated with a higher risk of sudden cardiac death due to their potential to conduct rapidly during AF.</li><li>\u2022 Option D. Accessory pathway in the posteroseptal region:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 High risk in WPW = multiple accessory pathways, accessory pathway refractory period < 240ms, inducible AVRT or AF in EPS & shortest RR in AF \u2264 250ms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "356f1da0",
      "audio": ""
    },
    {
      "text": "A 76-year-old woman with a history of hypertension, COPD, diabetes and osteoporosis presents to the emergency department after a fall, with intense left hip pain, dry mucous membranes, and tachycardia. Her ECG is shown. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Adenosine 6 mg IV",
          "correct": false
        },
        {
          "label": "B",
          "text": "Synchronized DCC",
          "correct": false
        },
        {
          "label": "C",
          "text": "Verapamil 5 mg IV",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pain control and IV hydration",
          "correct": true
        }
      ],
      "correct_answer": "D. Pain control and IV hydration",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-095717.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Adenosine 6 mg IV: Primarily used for supraventricular tachycardia (SVT), not MAT.</li><li>\u2022 Option A. Adenosine 6 mg IV:</li><li>\u2022 Option B. Synchronized DCC: Not effective for MAT and it is C/I.</li><li>\u2022 Option B. Synchronized DCC:</li><li>\u2022 Option C. Verapamil 5 mg IV: Verapamil may be in helpful in some patients with MAT (for rate control) but often unnecessary as treatment of underlying cause is sufficient and the most important.</li><li>\u2022 Option C. Verapamil 5 mg IV:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The initial management of MAT should focus on addressing the underlying causes, such as pain and dehydration in this case.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4bbc7307",
      "audio": ""
    },
    {
      "text": "Which of the following statements is true regarding the most common form of paroxysmal supraventricular tachycardia (PSVT)?",
      "options": [
        {
          "label": "A",
          "text": "It is usually life-threatening.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It relies on enhanced automaticity as a mechanism.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It relies on multiple pathways for conduction from the atrium into the AV node.",
          "correct": true
        },
        {
          "label": "D",
          "text": "It requires systemic anticoagulation for thromboembolic prophylaxis.",
          "correct": false
        }
      ],
      "correct_answer": "C. It relies on multiple pathways for conduction from the atrium into the AV node.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. It is usually life-threatening: AVNRT is usually not life-threatening, though it can cause significant symptoms.</li><li>\u2022 Option A. It is usually life-threatening:</li><li>\u2022 Option B. It relies on enhanced automaticity as a mechanism: AVNRT is a re-entry tachycardia, not caused by enhanced automaticity.</li><li>\u2022 Option B. It relies on enhanced automaticity as a mechanism:</li><li>\u2022 Option D. It requires systemic anticoagulation for thromboembolic prophylaxis: Anticoagulation is not typically required for AVNRT unless there are additional risk factors for thromboembolism.</li><li>\u2022 Option D. It requires systemic anticoagulation for thromboembolic prophylaxis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The most common form of PSVT is AVNRT, which is caused by re-entry circuits involving multiple pathways within the AV node.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0ef9eef8",
      "audio": ""
    },
    {
      "text": "You are in the emergency department when a 19-year-old woman, Ms. Vidhya, arrives after collapsing during a Sunday marathon. She is unresponsive and pulseless. ECG is shown. Which of the following rhythms is the cause of her cardiac arrest?",
      "options": [
        {
          "label": "A",
          "text": "AF with pre-excitation",
          "correct": true
        },
        {
          "label": "B",
          "text": "AF with LBBB",
          "correct": false
        },
        {
          "label": "C",
          "text": "Monomorphic VT",
          "correct": false
        },
        {
          "label": "D",
          "text": "Torsades de pointes",
          "correct": false
        }
      ],
      "correct_answer": "A. AF with pre-excitation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-095925.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Atrioventricular nodal reentrant tachycardia: This is usually a narrow-complex tachycardia, unlike the wide-complex seen in this case.</li><li>\u2022 Option B. Atrioventricular nodal reentrant tachycardia:</li><li>\u2022 Option C. Monomorphic ventricular tachycardia: This has a regular rhythm with similar QRS complexes, unlike the irregular pattern seen here.</li><li>\u2022 Option C. Monomorphic ventricular tachycardia:</li><li>\u2022 Option D. Torsades de pointes: Difficult to differentiate but the given ECG does not have the twisting morphology to consider it as Torsades de pointes.</li><li>\u2022 Option D. Torsades de pointes:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 AF with preexcitation presents with rapid irregular wide-complex tachycardia and it is lethal.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8dc9bb11",
      "audio": ""
    },
    {
      "text": "Which of the following statements regarding the below rhythm is false?",
      "options": [
        {
          "label": "A",
          "text": "Catheter ablation has a high success rate in common atrial flutter.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is dependent on the cavotricuspid isthmus for conduction.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.",
          "correct": true
        },
        {
          "label": "D",
          "text": "The wave of depolarization propagates anti-clockwise",
          "correct": false
        }
      ],
      "correct_answer": "C. Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100045.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100137.png"
      ],
      "explanation": "<p><strong>Ans. C) Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Catheter ablation has a high success rate in common atrial flutter: True. It has > 95% success.</li><li>\u2022 Option A. Catheter ablation has a high success rate in common atrial flutter:</li><li>\u2022 Option B. It is dependent on the cavotricuspid isthmus for conduction: True. Since the wavefront passes in the cavotricuspid isthmus, where it is susceptible to interruption by catheter ablation.</li><li>\u2022 Option B. It is dependent on the cavotricuspid isthmus for conduction:</li><li>\u2022 Option D. The wave of depolarization propagates anti-clockwise: The circuit most commonly revolves in a counterclockwise direction (as viewed looking toward the tricuspid annulus from the ventricular apex), which produces the characteristic negative sawtooth flutter waves in leads II, III, and aVF and positive P waves in lead V1.</li><li>\u2022 Option D. The wave of depolarization propagates anti-clockwise:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Catheter ablation is a highly effective treatment for typical atrial flutter, offering high success rates and a low risk of complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eacf9105",
      "audio": ""
    },
    {
      "text": "Mr. Sarabesh presents with palpitations. His ECG is shown. Which of the following is false regarding the rhythm?",
      "options": [
        {
          "label": "A",
          "text": "Incidence increases with age.",
          "correct": false
        },
        {
          "label": "B",
          "text": "More common in women than in men.",
          "correct": true
        },
        {
          "label": "C",
          "text": "It is associated with an increased risk of mortality.",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above.",
          "correct": false
        }
      ],
      "correct_answer": "B. More common in women than in men.",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100253.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. True. The incidence of AF increases with age.</li><li>\u2022 Option A.</li><li>\u2022 Option C. True. AF is associated with an increased risk of mortality.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Not all of the above statements are false. Option A and C are true.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Atrial fibrillation is the most common sustained arrhythmia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9932b1dd",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with a history of pacemaker insertion presents to you for routine review. You notice the pacemaker site like what is shown in the image. What is the most appropriate additional management?",
      "options": [
        {
          "label": "A",
          "text": "Aspiration of the device pocket",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pacemaker extraction",
          "correct": true
        },
        {
          "label": "C",
          "text": "Topical mupirocin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Clinical observation and reassessment",
          "correct": false
        }
      ],
      "correct_answer": "B. Pacemaker extraction",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092200.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Aspiration: Not recommended for diagnostic purposes and can worsen infection.</li><li>\u2022 Option A. Aspiration:</li><li>\u2022 Option C. Topical mupirocin: Ineffective for deep pocket infection.</li><li>\u2022 Option C. Topical mupirocin:</li><li>\u2022 Option D. Observation: Inappropriate as the infection can worsen and lead to serious complications.</li><li>\u2022 Option D. Observation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prompt device removal and antibiotic therapy is required in cases of suspected or confirmed cardiac device infection.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4be9dd33",
      "audio": ""
    },
    {
      "text": "Ms. Kavitha, a 22-year-old woman with rheumatic mitral stenosis develops atrial fibrillation. Her CHA\u2082DS\u2082-VASc is 1. Which of the following is the correct approach to stroke prevention?",
      "options": [
        {
          "label": "A",
          "text": "No anticoagulation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Initiate aspirin 325 mg daily",
          "correct": false
        },
        {
          "label": "C",
          "text": "Initiate apixaban 5 mg twice daily",
          "correct": false
        },
        {
          "label": "D",
          "text": "Initiate warfarin",
          "correct": true
        }
      ],
      "correct_answer": "D. Initiate warfarin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. No anticoagulation: Incorrect, since AF increases the risk of stroke by 20-25x in patients with mitral stenosis.</li><li>\u2022 Option A. No anticoagulation:</li><li>\u2022 Option C. Initiate aspirin 325 mg daily: Insufficient for stroke prevention in patients with AF and high risk factors like rheumatic mitral stenosis.</li><li>\u2022 Option C. Initiate aspirin 325 mg daily:</li><li>\u2022 Option D. Initiate apixaban 5 mg twice daily: DOACs are not recommended in patients with rheumatic mitral stenosis due to limited data.</li><li>\u2022 Option D. Initiate apixaban 5 mg twice daily:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Warfarin is the recommended anticoagulant for stroke prevention in patients with AF and rheumatic mitral stenosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b988eb41",
      "audio": ""
    }
  ]
}